-
1
-
-
0027192259
-
Atherosclerosis: Current understanding of mechanisms and future strategies in therapy
-
Ross, R. Atherosclerosis: Current understanding of mechanisms and future strategies in therapy. Transplant. Proc., 1993, 25, 2041-2043. (Pubitemid 23125199)
-
(1993)
Transplantation Proceedings
, vol.25
, Issue.2
, pp. 2041-2043
-
-
Ross, R.1
-
2
-
-
0033552883
-
Atherosclerosis -an inflammatory disease
-
Ross, R. Atherosclerosis -an inflammatory disease. N. Engl. J. Med., 1999, 340, 115-126.
-
(1999)
N. Engl. J. Med.
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
3
-
-
20444410946
-
New links between inflammation and thrombosis
-
DOI 10.1161/01.ATV.0000166521.90532.44
-
Wagner, D.D. New links between inflammation and thrombosis. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 1321-1324. (Pubitemid 40923346)
-
(2005)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.25
, Issue.7
, pp. 1321-1324
-
-
Wagner, D.D.1
-
4
-
-
78650413994
-
Platelet-leukocyte interactions in cardiovascular disease and beyond
-
Totani, L.; Evangelista, V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 2357-2361.
-
(2010)
Arterioscler. Thromb. Vasc. Biol.
, vol.30
, pp. 2357-2361
-
-
Totani, L.1
Evangelista, V.2
-
5
-
-
0037180771
-
Inflammation in atherosclerosis
-
DOI 10.1038/nature01323
-
Libby, P. Inflammation in atherosclerosis. Nature, 2002, 420, 868-874. (Pubitemid 36019640)
-
(2002)
Nature
, vol.420
, Issue.6917
, pp. 868-874
-
-
Libby, P.1
-
6
-
-
0141919739
-
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
-
DOI 10.1161/01.CIR.0000091201.39590.CB
-
Peters, R.J.; Mehta, S.R.; Fox, K.A.; Zhao, F.; Lewis, B.S.; Kopecky, S.L.; Diaz, R.; Commerford, P.J.; Valentin, V.; Yusuf, S.; Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation, 2003, 108, 1682-1687. (Pubitemid 37243654)
-
(2003)
Circulation
, vol.108
, Issue.14
, pp. 1682-1687
-
-
Peters, R.J.G.1
Mehta, S.R.2
Fox, K.A.A.3
Zhao, F.4
Lewis, B.S.5
Kopecky, S.L.6
Diaz, R.7
Commerford, P.J.8
Valentin, V.9
Yusuf, S.10
-
7
-
-
1542708471
-
Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
-
DOI 10.1016/j.jacc.2003.12.034, PII S0735109704001731
-
Chen, W.H.; Lee, P.Y.; Ng, W.; Tse, H.F.; Lau, C.P. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J. Am. Coll. Cardiol., 2004, 43, 1122-1126. (Pubitemid 38353000)
-
(2004)
Journal of the American College of Cardiology
, vol.43
, Issue.6
, pp. 1122-1126
-
-
Chen, W.-H.1
Lee, P.-Y.2
Ng, W.3
Tse, H.-F.4
Lau, C.-P.5
-
8
-
-
0023911669
-
Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure
-
Erne, P.; Wardle, J.; Sanders, K.; Lewis, S.M.; Maseri, A. Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure. Thromb. Haemost., 1988, 59, 259-263.
-
(1988)
Thromb. Haemost.
, vol.59
, pp. 259-263
-
-
Erne, P.1
Wardle, J.2
Sanders, K.3
Lewis, S.M.4
Maseri, A.5
-
9
-
-
0037769793
-
Platelet P-selectin facilitates atherosclerotic lesion development
-
DOI 10.1182/blood-2002-07-2209
-
Burger, P.C.; Wagner, D.D. Platelet P-selectin facilitates atherosclerotic lesion development. Blood, 2003, 101, 2661-2666. (Pubitemid 36857627)
-
(2003)
Blood
, vol.101
, Issue.7
, pp. 2661-2666
-
-
Burger, P.C.1
Wagner, D.D.2
-
10
-
-
0037231665
-
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
-
DOI 10.1038/nm810
-
Huo, Y.; Schober, A.; Forlow, S.B.; Smith, D.F.; Hyman, M.C.; Jung, S.; Littman, D.R.; Weber, C.; Ley, K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med., 2003, 9, 61-67. (Pubitemid 36098261)
-
(2003)
Nature Medicine
, vol.9
, Issue.1
, pp. 61-67
-
-
Huo, Y.1
Schober, A.2
Forlow, S.B.3
Smith, D.F.4
Hyman, M.C.5
Jung, S.6
Littman, D.R.7
Weber, C.8
Ley, K.9
-
11
-
-
0022049305
-
Biochemistry of alpha granule proteins
-
Holt, J,C.; Niewiarowski, S. Biochemistry of alpha granule proteins. Semin. Hematol., 1985, 22, 151-163.
-
(1985)
Semin. Hematol.
, vol.22
, pp. 151-163
-
-
Holt, J.C.1
Niewiarowski, S.2
-
12
-
-
1642634539
-
Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation
-
DOI 10.1016/j.molmed.2004.02.008, PII S1471491404000565
-
Furie, B.; Furie, B.C. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends. Mol. Med., 2004, 10, 171-178. (Pubitemid 38410975)
-
(2004)
Trends in Molecular Medicine
, vol.10
, Issue.4
, pp. 171-178
-
-
Furie, B.1
Furie, B.C.2
-
13
-
-
2942665644
-
The emerging value of P-selection as a disease marker
-
DOI 10.1515/CCLM.2004.082
-
Kappelmayer, J.; Nagy, B. Jr.; Miszti-Blasius, K.; Hevessy, Z.; Setiadi, H. The emerging value of P-selectin as a disease marker. Clin. Chem. Lab. Med., 2004, 42, 475-486. (Pubitemid 38779747)
-
(2004)
Clinical Chemistry and Laboratory Medicine
, vol.42
, Issue.5
, pp. 475-486
-
-
Kappelmayer, J.1
Nagy Jr., B.2
Miszti-Blasius, K.3
Hevessy, Z.4
Setiadi, H.5
-
14
-
-
12444303861
-
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin
-
DOI 10.1084/jem.20021868
-
Falati, S.; Liu, Q.; Gross, P.; Merrill-Skoloff, G.; Chou, J.; Vandendries, E.; Celi, A., Croce, K.; Furie, B.C.; Furie, B. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J. Exp. Med., 2003, 197, 1585-1598. (Pubitemid 36682554)
-
(2003)
Journal of Experimental Medicine
, vol.197
, Issue.11
, pp. 1585-1598
-
-
Falati, S.1
Liu, Q.2
Gross, P.3
Merrill-Skoloff, G.4
Chou, J.5
Vandendries, E.6
Celi, A.7
Croce, K.8
Furie, B.C.9
Furie, B.10
-
15
-
-
0030938510
-
Human chemokines: An update
-
DOI 10.1146/annurev.immunol.15.1.675
-
Baggiolini, M.; Dewald, B.; Moser, B. Human chemokines: An update. Annu. Rev. Immunol., 1997, 15, 675-705. (Pubitemid 27169296)
-
(1997)
Annual Review of Immunology
, vol.15
, pp. 675-705
-
-
Baggiolini, M.1
Dewald, B.2
Moser, B.3
-
16
-
-
0032891619
-
Recent advances in chemokines and chemokine receptors
-
Zlotnik, A.; Morales, J.; Hedrick, J.A. Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol., 1999, 19, 1-47. (Pubitemid 29062100)
-
(1999)
Critical Reviews in Immunology
, vol.19
, Issue.1
, pp. 1-47
-
-
Zlotnik, A.1
Morales, J.2
Hedrick, J.A.3
-
17
-
-
0035673503
-
Platelet chemokines and their receptors: What is their relevance to platelet storage and transfusion practice?
-
DOI 10.1046/j.1365-3148.2001.00340.x
-
Boehlen, F.; Clemetson, K.J. Platelet chemokines and their receptors: What is their relevance to platelet storage and transfusion practice? Transfus. Med., 2001, 11, 403-417. (Pubitemid 34044850)
-
(2001)
Transfusion Medicine
, vol.11
, Issue.6
, pp. 403-417
-
-
Boehlen, F.1
Clemetson, K.J.2
-
18
-
-
55449101135
-
Platelet chemokines in vascular disease
-
Gleissner, C.A.; von Hundelshausen, P.; Ley, K. Platelet chemokines in vascular disease. Arterioscler. Thromb. Vasc. Biol., 2008, 28, 1920-1927.
-
(2008)
Arterioscler. Thromb. Vasc. Biol.
, vol.28
, pp. 1920-1927
-
-
Gleissner, C.A.1
Von Hundelshausen, P.2
Ley, K.3
-
19
-
-
0347043610
-
Platelet factor 4 localization in carotid atherosclerotic plaques: Correlation with clinical parameters
-
Pitsilos, S.; Hunt, J.; Mohler, E.R.; Prabhakar, A.M.; Poncz, M.; Dawicki, J.; Khalapyan, T.Z.; Wolfe, M.L.; Fairman, R.; Mitchell, M.; Carpenter, J.; Golden, M.A.; Cines, D.B.; Sachais, B.S. Platelet factor 4 localization in carotid atherosclerotic plaques: Correlation with clinical parameters. Thromb. Haemost., 2003, 90, 1112-1120. (Pubitemid 38004432)
-
(2003)
Thrombosis and Haemostasis
, vol.90
, Issue.6
, pp. 1112-1120
-
-
Pitsilos, S.1
Hunt, J.2
Mohler, E.R.3
Prabhakar, A.M.4
Poncz, M.5
Dawicki, J.6
Khalapyan, T.Z.7
Wolfe, M.L.8
Fairman, R.9
Mitchell, M.10
Carpenter, J.11
Golden, M.A.12
Cines, D.B.13
Sachais, B.S.14
-
20
-
-
0032484987
-
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
-
DOI 10.1038/35393
-
Henn, V.; Slupsky, J.R.; Gräfe, M.; Anagnostopoulos, I.; Förster, R.; Müller-Berghaus, G.; Kroczek, R.A. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature, 1998, 391, 591-594. (Pubitemid 28157601)
-
(1998)
Nature
, vol.391
, Issue.6667
, pp. 591-594
-
-
Henn, V.1
Slupsky, J.R.2
Grafe, M.3
Anagnostopoulos, I.4
Forster, R.5
Muller-Berghaus, G.6
Kroczek, R.A.7
-
21
-
-
0842321794
-
Cutting Edge: T Cells Trigger CD40-Dependent Platelet Activation and Granular RANTES Release: A Novel Pathway for Immune Response Amplification
-
Danese, S.; de la Motte, C.; Reyes, B.M.; Sans, M.; Levine, A.D.; Fiocchi, C. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: A novel pathway for immune response amplification. J. Immunol., 2004, 172, 2011-2015. (Pubitemid 38182345)
-
(2004)
Journal of Immunology
, vol.172
, Issue.4
, pp. 2011-2015
-
-
Danese, S.1
De La Motte, C.2
Rivera Reyes, B.M.3
Sans, M.4
Levine, A.D.5
Fiocchi, C.6
-
22
-
-
0021194362
-
A monoclonal antibody to a membrane glycoprotein binds only to activated platelets
-
McEver, R.P.; Martin, M.N. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J. Biol. Chem., 1984, 259, 9799-9804. (Pubitemid 14058590)
-
(1984)
Journal of Biological Chemistry
, vol.259
, Issue.15
, pp. 9799-9804
-
-
McEver, R.P.1
Martin, M.N.2
-
23
-
-
0021180126
-
A platelet membrane protein expressed during platelet activation and secretion
-
Hsu-Lin, S.C.; Berman, C.L.; Furie, B.C.; August, D.; Furie, B. A platelet membrane protein expressed during platelet activation and secretion. J. Biol. Chem., 1984, 259, 9121-9126.
-
(1984)
J. Biol. Chem.
, vol.259
, pp. 9121-9126
-
-
Hsu-Lin, S.C.1
Berman, C.L.2
Furie, B.C.3
August, D.4
Furie, B.5
-
25
-
-
0024558097
-
Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation
-
DOI 10.1016/0092-8674(89)90636-3
-
Johnston, G.I.; Cook, R.G.; McEver, R.P. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation. Cell, 1989, 56, 1033-1044. (Pubitemid 19091015)
-
(1989)
Cell
, vol.56
, Issue.6
, pp. 1033-1044
-
-
Johnston, G.I.1
Cook, R.G.2
McEver, R.P.3
-
26
-
-
0024364675
-
GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies
-
McEver, R.P., Beckstead, J,M.; Moore, K.L.; Marshall-Carlson, L.; Bainton, D.F. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J. Clin. Invest., 1989, 84, 92-99. (Pubitemid 19170099)
-
(1989)
Journal of Clinical Investigation
, vol.84
, Issue.1
, pp. 92-99
-
-
McEver, R.P.1
Beckstead, J.H.2
Moore, K.L.3
Marshall-Carlson, L.4
Bainton, D.F.5
-
27
-
-
0030922560
-
Re-expression of functional P-selectin molecules on the endothelial cell surface by repeated stimulation with thrombin
-
Kameda, H.; Morita, I.; Handa, M.; Kaburaki, J.; Yoshida, T.; Mimori, T.; Murota, S.; Ikeda, Y. Re-expression of functional P-selectin molecules on the endothelial cell surface by repeated stimulation with thrombin. Br. J. Haematol., 1997, 97, 348-355. (Pubitemid 27224617)
-
(1997)
British Journal of Haematology
, vol.97
, Issue.2
, pp. 348-355
-
-
Kameda, H.1
Morita, I.2
Handa, M.3
Kaburaki, J.4
Yoshida, T.5
Mimori, T.6
Murota, S.-I.7
Ikeda, Y.8
-
29
-
-
0032904627
-
Mechanisms that regulate the function of the selectins and their ligands
-
Vestweber, D.; Blanks, J.E. Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev., 1999, 79, 181-213. (Pubitemid 29056952)
-
(1999)
Physiological Reviews
, vol.79
, Issue.1
, pp. 181-213
-
-
Vestweber, D.1
Blanks, J.E.2
-
30
-
-
0029973981
-
In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function
-
DOI 10.1073/pnas.93.21.11877
-
Michelson, A.D.; Barnard, M.R.; Hechtman, H.B.; MacGregor, H.; Connolly, R.J.; Loscalzo, J.; Valeri, C.R. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc. Natl. Acad. Sci. USA, 1996, 93, 11877-11882. (Pubitemid 26347217)
-
(1996)
Proceedings of the National Academy of Sciences of the United States of America
, vol.93
, Issue.21
, pp. 11877-11882
-
-
Michelson, A.D.1
Barnard, M.R.2
Hechtman, H.B.3
Macgregor, H.4
Connolly, R.J.5
Loscalzo, J.6
Valeri, C.R.7
-
31
-
-
0028843820
-
Residues throughout the cytoplasmic domain affect the internalization efficiency of P-selectin
-
Setiadi, H.; Disdier, M.; Green, S.A.; Canfield, W.M.; McEver, R.P. Residues throughout the cytoplasmic domain affect the internalization efficiency of P-selectin. J. Biol. Chem., 1995, 270, 26818-26826.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 26818-26826
-
-
Setiadi, H.1
Disdier, M.2
Green, S.A.3
Canfield, W.M.4
McEver, R.P.5
-
32
-
-
0028860321
-
P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin
-
Moore, K.L.; Patel, K.D.; Bruehl, R.E.; Li, F., Johnson, D.A.; Lichenstein, H.S.; Cummings, R.D.; Bainton, D.F. McEver, R.P. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J. Cell. Biol., 1995, 128, 661-671.
-
(1995)
J. Cell. Biol.
, vol.128
, pp. 661-671
-
-
Moore, K.L.1
Patel, K.D.2
Bruehl, R.E.3
Li, F.4
Johnson, D.A.5
Lichenstein, H.S.6
Cummings, R.D.7
Bainton, D.F.8
McEver, R.P.9
-
33
-
-
0034678355
-
P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo
-
DOI 10.1084/jem.191.8.1413
-
Frenette, P.S.; Denis, C.V.; Weiss, L.; Jurk, K.; Subbarao, S.; Kehrel, B.; Hartwig, J.H.; Vestweber, D.; Wagner, D.D. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J. Exp. Med., 2000, 191, 1413-1422. (Pubitemid 30227127)
-
(2000)
Journal of Experimental Medicine
, vol.191
, Issue.8
, pp. 1413-1422
-
-
Frenette, P.S.1
Denis, C.V.2
Weiss, L.3
Jurk, K.4
Subbarao, S.5
Kehrel, B.6
Hartwig, J.H.7
Vestweber, D.8
Wagner, D.D.9
-
34
-
-
2442519018
-
Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation
-
Ley, K.; Kansas, G.S. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat. Rev. Immunol., 2004, 4, 325-335. (Pubitemid 38649275)
-
(2004)
Nature Reviews Immunology
, vol.4
, Issue.5
, pp. 325-335
-
-
Ley, K.1
Kansas, G.S.2
-
35
-
-
11244347898
-
P-selectin in arterial thrombosis
-
DOI 10.1007/s00392-004-0146-5
-
Merten, M.; Thiagarajan, P. P-selectin in arterial thrombosis. Z. Kardiol., 2004, 93, 855-863. (Pubitemid 40064238)
-
(2004)
Zeitschrift fur Kardiologie
, vol.93
, Issue.11
, pp. 855-863
-
-
Merten, M.1
Thiagarajan, P.2
-
36
-
-
27144476793
-
Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: Role of P-selectin
-
DOI 10.1182/blood-2005-04-1530
-
Dole, V.S.; Bergmeier, W.; Mitchell, H.A.; Eichenberger, S.C.; Wagner, D.D. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: Role of P-selectin. Blood, 2005, 106, 2334-2339. (Pubitemid 41510804)
-
(2005)
Blood
, vol.106
, Issue.7
, pp. 2334-2339
-
-
Dole, V.S.1
Bergmeier, W.2
Mitchell, H.A.3
Eichenberger, S.C.4
Wagner, D.D.5
-
37
-
-
0027935309
-
Leukocyte-endothelial adhesion molecules
-
Carlos, T.M.; Harlan, J.M. Leukocyte-endothelial adhesion molecules. Blood, 1994, 84, 2068-2101. (Pubitemid 24296363)
-
(1994)
Blood
, vol.84
, Issue.7
, pp. 2068-2101
-
-
Carlos, T.M.1
Harlan, J.M.2
-
38
-
-
0026495238
-
Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets
-
Palabrica, T.; Lobb, R.; Furie, B.C.; Aronovitz, M.; Benjamin, C.; Hsu, Y.M.; Sajer, S.A.; Furie, B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature, 1992, 359, 848-851.
-
(1992)
Nature
, vol.359
, pp. 848-851
-
-
Palabrica, T.1
Lobb, R.2
Furie, B.C.3
Aronovitz, M.4
Benjamin, C.5
Hsu, Y.M.6
Sajer, S.A.7
Furie, B.8
-
39
-
-
0030049002
-
Defects in hemostasis in P-selectin-deficient mice
-
Subramaniam, M.; Frenette, P.S.; Saffaripour, S.; Johnson, R.C.; Hynes, R.O.; Wagner, D.D. Defects in hemostasis in P-selectin-deficient mice. Blood, 1996, 87, 1238-1242. (Pubitemid 26056885)
-
(1996)
Blood
, vol.87
, Issue.4
, pp. 1238-1242
-
-
Subramaniam, M.1
Frenette, P.S.2
Saffaripour, S.3
Johnson, R.C.4
Hynes, R.O.5
Wagner, D.D.6
-
40
-
-
0041965943
-
Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A
-
DOI 10.1038/nm899
-
Hrachovinová, I.; Cambien, B.; Hafezi-Moghadam, A.; Kappelmayer, J.; Camphausen, R.T.; Widom, A.; Xia, L.; Kazazian, H.H. Jr., Schaub, R.G.; McEver, R.P.; Wagner, D.D. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat. Med., 2003, 9, 1020-1025. (Pubitemid 37021781)
-
(2003)
Nature Medicine
, vol.9
, Issue.8
, pp. 1020-1025
-
-
Hrachovinova, I.1
Cambien, B.2
Hafezi-Moghadam, A.3
Kappelmayer, J.4
Camphausen, R.T.5
Widom, A.6
Xia, L.7
Kazazian Jr., H.H.8
Schaub, R.G.9
McEver, R.P.10
Wagner, D.D.11
-
41
-
-
0029993531
-
Activated platelets signal chemokine synthesis by human monocytes
-
Weyrich, A.S.; Elstad, M.R.; McEver, R.P.; McIntyre, T.M.; Moore, K.L.; Morrissey, J.H.; Prescott, S.M.; Zimmerman, G.A. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest., 1996, 97, 1525-1534. (Pubitemid 26097043)
-
(1996)
Journal of Clinical Investigation
, vol.97
, Issue.6
, pp. 1525-1534
-
-
Weyrich, A.S.1
Elstad, M.R.2
McEver, R.P.3
McIntyre, T.M.4
Moore, K.L.5
Morrissey, J.H.6
Prescott, S.M.7
Zimmerman, G.A.8
-
42
-
-
0035969983
-
Soluble P-selectin and the risk of future cardiovascular events
-
Ridker, P.M.; Buring, J.E.; Rifai, N. Soluble P-selectin and the risk of future cardiovascular events. Circulation, 2001, 103, 491-495. (Pubitemid 32116231)
-
(2001)
Circulation
, vol.103
, Issue.4
, pp. 491-495
-
-
Ridker, P.M.1
Buring, J.E.2
Rifai, N.3
-
43
-
-
0028128695
-
Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule
-
Ishiwata, N.; Takio, K.; Katayama, M.; Watanabe, K.; Titani, K.; Ikeda, Y.; Handa, M. Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J. Biol. Chem., 1994, 269, 23708-23715. (Pubitemid 24293578)
-
(1994)
Journal of Biological Chemistry
, vol.269
, Issue.38
, pp. 23708-23715
-
-
Ishiwata, N.1
Takio, K.2
Katayama, M.3
Watanabe, K.4
Titani, K.5
Ikeda, Y.6
Handa, M.7
-
44
-
-
0030749941
-
Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers
-
Blann, A.D.; Lip, G.Y.; Beevers, D.G.; McCollum, C.N. Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers. Thromb. Haemost., 1997, 77, 1077-1080. (Pubitemid 27311972)
-
(1997)
Thrombosis and Haemostasis
, vol.77
, Issue.6
, pp. 1077-1080
-
-
Blann, A.D.1
Lip, G.Y.H.2
Beevers, D.G.3
McCollum, C.N.4
-
45
-
-
0030794650
-
The origin of P-selectin as a circulating plasma protein
-
Fijnheer, R.; Frijns, C.J.; Korteweg, J.; Rommes, H.; Peters, J.H.; Sixma, J.J.; Nieuwenhuis, H.K. The origin of P-selectin as a circulating plasma protein. Thromb. Haemost., 1997, 77, 1081-1085. (Pubitemid 27311973)
-
(1997)
Thrombosis and Haemostasis
, vol.77
, Issue.6
, pp. 1081-1085
-
-
Fijnheer, R.1
Frijns, C.J.M.2
Korteweg, J.3
Rommes, H.4
Peters, J.H.5
Sixma, J.J.6
Nieuwenhuis, H.K.7
-
46
-
-
33644833413
-
Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion
-
DOI 10.1161/01.RES.0000199295.14073.69, PII 0000301220060106000022
-
Woollard, K.J.; Kling, D.; Kulkarni, S.; Dart, A.M.; Jackson, S.; Chin-Dusting, J. Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ. Res., 2006, 98, 149-156. (Pubitemid 43970215)
-
(2006)
Circulation Research
, vol.98
, Issue.1
, pp. 149-156
-
-
Woollard, K.J.1
Kling, D.2
Kulkarni, S.3
Dart, A.M.4
Jackson, S.5
Chin-Dusting, J.6
-
47
-
-
18244378804
-
Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes
-
DOI 10.1161/01.ATV.0000159094.17235.9b
-
del Conde, I.; Nabi, F.; Tonda, R.; Thiagarajan, P.; López, J.A.; Kleiman, N.S. Effect of P-selectin on phosphatidylserine exposure and surfacedependent thrombin generation on monocytes. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 1065-1070. (Pubitemid 40627856)
-
(2005)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.25
, Issue.5
, pp. 1065-1070
-
-
Del Conde, I.1
Nabi, F.2
Tonda, R.3
Thiagarajan, P.4
Lopez, J.A.5
Kleiman, N.S.6
-
48
-
-
23944509766
-
Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation
-
DOI 10.1182/blood-2004-03-1095
-
del Conde, I.; Shrimpton, C.N.; Thiagarajan, P.; López, J.A. Tissue-factorbearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood, 2005, 106, 1604-1611. (Pubitemid 41208572)
-
(2005)
Blood
, vol.106
, Issue.5
, pp. 1604-1611
-
-
Del Conde, I.1
Shrimpton, C.N.2
Thiagarajan, P.3
Lopez, J.A.4
-
49
-
-
0032538997
-
Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses
-
DOI 10.1083/jcb.143.4.1129
-
Hartwell, D.W.; Mayadas, T.N.; Berger, G.; Frenette, P.S.; Rayburn, H.; Hynes, R.O.; Wagner, D.D. Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J. Cell. Biol., 1998, 143, 1129-1141. (Pubitemid 28547409)
-
(1998)
Journal of Cell Biology
, vol.143
, Issue.4
, pp. 1129-1141
-
-
Hartwell, D.W.1
Mayadas, T.N.2
Berger, G.3
Frenette, P.S.4
Rayburn, H.5
Hynes, R.O.6
Wagner, D.D.7
-
50
-
-
0025126358
-
Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP-140
-
Gamble, J.R.; Skinner, M.P.; Berndt, M.C.; Vadas, M.A. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP-140. Science, 1990, 249, 414-417.
-
(1990)
Science
, vol.249
, pp. 414-417
-
-
Gamble, J.R.1
Skinner, M.P.2
Berndt, M.C.3
Vadas, M.A.4
-
51
-
-
0028346831
-
Plasma P-selectin is increased in thrombotic consumptive platelet disorders
-
Chong, B.H.; Murray, B.; Berndt, M.C.; Dunlop, L.C.; Brighton, T.; Chesterman, C.N. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood, 1994, 83, 1535-1541. (Pubitemid 24081566)
-
(1994)
Blood
, vol.83
, Issue.6
, pp. 1535-1541
-
-
Chong, B.H.1
Murray, B.2
Berndt, M.C.3
Dunlop, L.C.4
Brighton, T.5
Chesterman, C.N.6
-
52
-
-
0029143965
-
Increased soluble form of P-selectin in patients with unstable angina
-
Ikeda, H.; Takajo, Y.; Ichiki, K.; Ueno, T.; Maki, S.; Noda, T.; Sugi, K.; Imaizumi, T. Increased soluble form of P-selectin in patients with unstable angina. Circulation, 1995, 92, 1693-1696.
-
(1995)
Circulation
, vol.92
, pp. 1693-1696
-
-
Ikeda, H.1
Takajo, Y.2
Ichiki, K.3
Ueno, T.4
Maki, S.5
Noda, T.6
Sugi, K.7
Imaizumi, T.8
-
53
-
-
0036842239
-
Course of platelet activation markers after ischemic stroke
-
DOI 10.1161/01.STR.0000034398.34938.20
-
Marquardt, L.; Ruf, A.; Mansmann, U.; Winter, R.; Schuler, M.; Buggle, F.; Mayer, H.; Grau, A.J. Course of platelet activation markers after ischemic stroke. Stroke, 2002, 33, 2570-2574. (Pubitemid 35266425)
-
(2002)
Stroke
, vol.33
, Issue.11
, pp. 2570-2574
-
-
Marquardt, L.1
Ruf, A.2
Mansmann, U.3
Winter, R.4
Schuler, M.5
Buggle, F.6
Mayer, H.7
Grau, A.J.8
-
54
-
-
34247138810
-
Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension
-
DOI 10.1016/j.atherosclerosis.2006.04.028, PII S0021915006002413
-
Preston, R.A.; Coffey, J.O.; Materson, B.J.; Ledford, M.; Alonso, A.B. Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension. Atherosclerosis, 2007, 192, 148-154. (Pubitemid 46602291)
-
(2007)
Atherosclerosis
, vol.192
, Issue.1
, pp. 148-154
-
-
Preston, R.A.1
Coffey, J.O.2
Materson, B.J.3
Ledford, M.4
Alonso, A.B.5
-
55
-
-
34447529118
-
Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus
-
DOI 10.1160/TH06-11-0628
-
Nagy, B. Jr.; Csongrádi, E.; Bhattoa, H.P.; Balogh, I.; Blaskó, G.; Paragh, G.; Kappelmayer, J.; Káplár, M. Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus. Thromb. Haemost., 2007, 98, 186-191. (Pubitemid 47074195)
-
(2007)
Thrombosis and Haemostasis
, vol.98
, Issue.1
, pp. 186-191
-
-
Nagy Jr., B.1
Csongradi, E.2
Bhattoa, H.P.3
Balogh, I.4
Blasko, G.5
Paragh, G.6
Kappelmayer, J.7
Kaplar, M.8
-
56
-
-
79953312640
-
Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia
-
Nagy, B. Jr.; Jin, J.; Ashby, B.; Reilly, M.P.; Kunapuli, S.P. Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia. J. Thromb. Haemost., 2011, 9, 810-819.
-
(2011)
J. Thromb. Haemost.
, vol.9
, pp. 810-819
-
-
Nagy, Jr.B.1
Jin, J.2
Ashby, B.3
Reilly, M.P.4
Kunapuli, S.P.5
-
57
-
-
80053206291
-
Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients
-
Csongrádi, É.; Nagy, B. Jr.; Fulop, T.; Varga, Z.; Karányi, Z.; Magyar, M.T.; Oláh, L.; Papp, M.; Facskó, A.; Kappelmayer, J.; Paragh, G.; Káplár, M. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients. Thromb Haemost., 2011, 106, 683-692.
-
(2011)
Thromb Haemost.
, vol.106
, pp. 683-692
-
-
Csongrádi, É.1
Nagy Jr., B.2
Fulop, T.3
Varga, Z.4
Karányi, Z.5
Magyar, M.T.6
Oláh, L.7
Papp, M.8
Facskó, A.9
Kappelmayer, J.10
Paragh, G.11
Káplár, M.12
-
58
-
-
0034543087
-
P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease
-
DOI 10.1097/00001721-200012000-00005
-
Zeiger, F.; Stephan, S.; Hoheisel, G.; Pfeiffer, D;, Ruehlmann, C.; Koksch, M. P-selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul. Fibrinolysis, 2000, 11, 723-728. (Pubitemid 32010206)
-
(2000)
Blood Coagulation and Fibrinolysis
, vol.11
, Issue.8
, pp. 723-728
-
-
Zeiger, F.1
Stephan, S.2
Hoheisel, G.3
Pfeiffer, D.4
Ruehlmann, C.5
Koksch, M.6
-
59
-
-
0033973002
-
Increased soluble P-selectin levels following deep venous thrombosis: Cause or effect?
-
DOI 10.1046/j.1365-2141.2000.01813.x
-
Blann, A.D.; Noteboom, W.M.; Rosendaal, F.R. Increased soluble P-selectin levels following deep venous thrombosis: Cause or effect? Br. J. Haematol., 2000, 108, 191-193. (Pubitemid 30089953)
-
(2000)
British Journal of Haematology
, vol.108
, Issue.1
, pp. 191-193
-
-
Blann, A.D.1
Noteboom, W.M.P.2
Rosendaal, F.R.3
-
60
-
-
0037783435
-
Prediction of recurrent events by d-dimer and inflammatory markers in patients with normal cardiac troponin I (PREDICT) study
-
DOI 10.1016/S0002-8703(03)00169-8
-
Menown, I.B.; Mathew, T.P.; Gracey, H.M.; Nesbitt, G.S.; Murray, P.; Young, I.S.; Adgey, A.A.; Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I Study. Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) Study. Am. Heart J., 2003, 145, 986-992. (Pubitemid 36688248)
-
(2003)
American Heart Journal
, vol.145
, Issue.6
, pp. 986-992
-
-
Menown, I.B.A.1
Mathew, T.P.2
Gracey, H.M.3
Nesbitt, G.S.4
Murray, P.5
Young, I.S.6
Adgey, A.A.J.7
-
61
-
-
79551498812
-
Low soluble P-selectin may facilitate early exclusion of acute myocardial infarction
-
Body, R.; Pemberton, P.; Ali, F.; McDowell, G.; Carley, S.; Smith, A.; Mackway-Jones, K. Low soluble P-selectin may facilitate early exclusion of acute myocardial infarction. Clin. Chim. Acta., 2011, 412, 614-618.
-
(2011)
Clin. Chim. Acta.
, vol.412
, pp. 614-618
-
-
Body, R.1
Pemberton, P.2
Ali, F.3
McDowell, G.4
Carley, S.5
Smith, A.6
Mackway-Jones, K.7
-
62
-
-
77950558991
-
High-sensitivity cardiac troponin T for early prediction of evolving non-STsegment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission
-
Giannitsis, E.; Becker, M.; Kurz, K.; Hess, G.; Zdunek, D.; Katus, H.A. High-sensitivity cardiac troponin T for early prediction of evolving non-STsegment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin. Chem., 2010, 56, 642-650.
-
(2010)
Clin. Chem.
, vol.56
, pp. 642-650
-
-
Giannitsis, E.1
Becker, M.2
Kurz, K.3
Hess, G.4
Zdunek, D.5
Katus, H.A.6
-
63
-
-
0031469109
-
Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice
-
Kumar, A.; Hoover, J.L.; Simmons, C.A.; Lindner, V.; Shebuski, R.J. Remodeling and neointimal formation in the carotid artery of normal and Pselectin-deficient mice. Circulation, 1997, 96, 4333-4342. (Pubitemid 28007463)
-
(1997)
Circulation
, vol.96
, Issue.12
, pp. 4333-4342
-
-
Kumar, A.1
Hoover, J.L.2
Simmons, C.A.3
Lindner, V.4
Shebuski, R.J.5
-
64
-
-
0035916306
-
Absence of P-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein E-deficient mice
-
Manka, D.; Collins, R.G.; Ley, K.; Beaudet, A.L.; Sarembock, I.J. Absence of P-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein e-deficient mice. Circulation, 2001, 103, 1000-1005. (Pubitemid 32183807)
-
(2001)
Circulation
, vol.103
, Issue.7
, pp. 1000-1005
-
-
Manka, D.1
Collins, R.G.2
Ley, K.3
Beaudet, A.L.4
Sarembock, I.J.5
-
65
-
-
0031857601
-
The P-selectin gene is highly polymorphic: Reduced frequency of the Pro715 allele carriers in patients with myocardial infarction
-
Herrmann, S.M.; Ricard, S.; Nicaud, V.; Mallet, C.; Evans, A.; Ruidavets, J.B.; Arveiler, D.; Luc, G.; Cambien, F. The P-selectin gene is highly polymorphic: Reduced frequency of the Pro715 allele carriers in pateints with myocardial infarction. Hum. Mol. Genet., 1998, 7, 1277-1284. (Pubitemid 28383061)
-
(1998)
Human Molecular Genetics
, vol.7
, Issue.8
, pp. 1277-1284
-
-
Herrmann, S.-M.1
Ricard, S.2
Nicaud, V.3
Mallet, C.4
Evans, A.5
Ruidavets, J.-B.6
Arveiler, D.7
Luc, G.8
Cambien, F.9
-
66
-
-
0033773743
-
Polymorphisms of the P-selectin gene and the risk of myocardial infarction in men and women in the ECTIM extension study
-
Kee, F.; Morrison, C.; Evans, A.; McCrum, E.; McMaster, D.; Dallongeville, J.; Nicaud, V.; Poirier, O.; Cambien, F. Polymorphisms of the P-selectin gene and the risk of myocardial infarction in men and women in the ECTIM extension study. Heart, 2000, 84, 548-552.
-
(2000)
Heart
, vol.84
, pp. 548-552
-
-
Kee, F.1
Morrison, C.2
Evans, A.3
McCrum, E.4
McMaster, D.5
Dallongeville, J.6
Nicaud, V.7
Poirier, O.8
Cambien, F.9
-
67
-
-
0035723419
-
Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease
-
Barbaux, S.C.; Blankenberg, S.; Rupprecht, H.J.; Francomme, C.; Bickel, C.; Hafner, G.; Nicaud, V.; Meyer, J.; Cambien, F.; Tiret, L. Associations between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Atheroscler. Thromb. Vasc. Biol., 2001, 21, 1668-1673. (Pubitemid 34215589)
-
(2001)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.21
, Issue.10
, pp. 1668-1673
-
-
Barbaux, S.C.1
Blankenberg, S.2
Rupprecht, H.J.3
Francomme, C.4
Bickel, C.5
Hafner, G.6
Nicaud, V.7
Meyer, J.8
Cambien, F.9
Tiret, L.10
-
68
-
-
2142811455
-
Soluble Pselectin levels, P-selectin polymorphisms and cardiovascular disease
-
Carter, A.M.; Anagnostopoulou, K.; Mansfield, M.W.; Grant, P.J. Soluble Pselectin levels, P-selectin polymorphisms and cardiovascular disease. J. Thromb. Haemost., 2003, 1, 1718-1723.
-
(2003)
J. Thromb. Haemost.
, vol.1
, pp. 1718-1723
-
-
Carter, A.M.1
Anagnostopoulou, K.2
Mansfield, M.W.3
Grant, P.J.4
-
69
-
-
9144226302
-
Association between the Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in a multiethnic population in South London
-
DOI 10.1160/TH04-04-0228
-
Miller, M.A.; Kerry, S.M.; Dong, Y.; Strazzullo, P.; Cappuccio, F.P. Associations between the Thr715Pro P-selectin gene polymorphism and soluble P-selectin in a multiethnic population in South London. Thromb. Haemost., 2004, 92, 1060-1065. (Pubitemid 39545530)
-
(2004)
Thrombosis and Haemostasis
, vol.92
, Issue.5
, pp. 1060-1065
-
-
Miller, M.A.1
Kerry, S.M.2
Dong, Y.3
Strazzullo, P.4
Cappuccio, F.P.5
-
70
-
-
26944501650
-
P-selectin gene haplotype associations with albuminuria in the Diabetes Heart Study
-
DOI 10.1111/j.1523-1755.2005.00452.x, PII 4494644
-
Liu, Y.; Burdon, K.P.; Langefeld, C.D.; Beck, S.R.; Wagenknecht, L.E.; Rich, S.S.; Bowden, D.W.; Freedman, B.I. P-selectin gene haplotype associations with albuminuria in the Diabetes Heart Study. Kidney Int., 2005, 68, 741-746. (Pubitemid 43323129)
-
(2005)
Kidney International
, vol.68
, Issue.2
, pp. 741-746
-
-
Liu, Y.1
Burdon, K.P.2
Langefeld, C.D.3
Beck, S.R.4
Wagenknecht, L.E.5
Rich, S.S.6
Bowden, D.W.7
Freedman, B.I.8
-
71
-
-
33645880123
-
P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: The atherosclerosis risk in communities study
-
Volcik, K.A.; Ballantyne, C.M.; Coresh, J.; Folsom, A.R.; Wu, K.K.; Boerwinkle, E. P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: The Atherosclerosis Risk In Communities Study. Atherosclerosis, 2006, 186, 74-79.
-
(2006)
Atherosclerosis
, vol.186
, pp. 74-79
-
-
Volcik, K.A.1
Ballantyne, C.M.2
Coresh, J.3
Folsom, A.R.4
Wu, K.K.5
Boerwinkle, E.6
-
72
-
-
9144263065
-
The Thr715Pro single nucleotide polymorphism of P-selectin: Does it really matter in cardiovascular or thrombotic disorders?
-
DOI 10.1160/TH04-09-0595
-
Jilma, B. The Thr715Pro single nucleotide polymorphism of P-selectin: Does it really matter in cardiovascular disorders? Thromb. Haemost., 2004, 92, 896-897. (Pubitemid 39545511)
-
(2004)
Thrombosis and Haemostasis
, vol.92
, Issue.5
, pp. 896-897
-
-
Jilma, B.1
-
73
-
-
67249143431
-
Thr715Pro P-selectin polymorphism and Pselectin release in blood obtained from the bleeding time wounds in patients with deep-vein thrombosis
-
Undas, A.; Tracz, W.; Siudak, Z. Thr715Pro P-selectin polymorphism and Pselectin release in blood obtained from the bleeding time wounds in patients with deep-vein thrombosis. Thromb. Res., 2009, 124, 248-250.
-
(2009)
Thromb. Res.
, vol.124
, pp. 248-250
-
-
Undas, A.1
Tracz, W.2
Siudak, Z.3
-
74
-
-
0037101844
-
Specific haplotypes of the P-selectin gene are associated with myocardial infarction
-
Tregouet, D.A.; Barbaux, S.; Escolano, S.; Tahri, N.; Golmard, J.L.; Tiret, L.; Cambien, F. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum. Mol. Genet., 2002, 11, 2015-2023. (Pubitemid 34919276)
-
(2002)
Human Molecular Genetics
, vol.11
, Issue.17
, pp. 2015-2023
-
-
Tregouet, D.-A.1
Barbaux, S.2
Escolano, S.3
Tahri, N.4
Golmard, J.-L.5
Tiret, L.6
Cambien, F.7
-
75
-
-
33747803921
-
P-selectin gene genotypes or haplotypes and cardiovascular complications in type 2 diabetes mellitus
-
DOI 10.1016/j.numecd.2005.07.002, PII S0939475305001481
-
Zalewski, G.; Ciccarone, E.; Di Castelnuovo, A.; Zito, F.; Capani, F.; de Gaetano, G.; Donati, M.B.; Iacoviello, L; GENDIABE investigators. Pselectin gene genotypes or haplotypes and cardiovascular complications in type 2 diabetes mellitus. Nutr. Metab. Cardiovasc. Dis., 2006, 16, 418-425. (Pubitemid 44279957)
-
(2006)
Nutrition, Metabolism and Cardiovascular Diseases
, vol.16
, Issue.6
, pp. 418-425
-
-
Zalewski, G.1
Ciccarone, E.2
Di Castelnuovo, A.3
Zito, F.4
Capani, F.5
De Gaetano, G.6
Donati, M.B.7
Iacoviello, L.8
-
76
-
-
35248836921
-
Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) study
-
DOI 10.1016/j.atherosclerosis.2007.03.007, PII S0021915007001712
-
Volcik, K.A.; Ballantyne, C.M.; Coresh, J.; Folsom, A.R.; Boerwinkle, E. Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis, 2007, 195, e76-82. (Pubitemid 47561962)
-
(2007)
Atherosclerosis
, vol.195
, Issue.1
-
-
Volcik, K.A.1
Ballantyne, C.M.2
Coresh, J.3
Folsom, A.R.4
Boerwinkle, E.5
-
77
-
-
78349274094
-
The P-selectin gene polymorphism Val168Met: A novel risk marker for the occurrence of primary ventricular fibrillation during acute myocardial infarction
-
Elmas, E.; Bugert, P.; Popp, T.; Lang, S.; Weiss, C.; Behnes, M.; Borggrefe, M.; Kälsch, T. The P-selectin gene polymorphism Val168Met: A novel risk marker for the occurrence of primary ventricular fibrillation during acute myocardial infarction. J. Cardiovasc. Electrophysiol., 2010, 21, 1260-1265.
-
(2010)
J. Cardiovasc. Electrophysiol.
, vol.21
, pp. 1260-1265
-
-
Elmas, E.1
Bugert, P.2
Popp, T.3
Lang, S.4
Weiss, C.5
Behnes, M.6
Borggrefe, M.7
Kälsch, T.8
-
78
-
-
0035874548
-
Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucinlike region
-
Afshar-Kharghan, V.; Diz-Küçükkaya, R.; Ludwig, E.H.; Marian, A.J.; López, J.A. Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucinlike region. Blood, 2001, 97, 3306-3307.
-
(2001)
Blood
, vol.97
, pp. 3306-3307
-
-
Afshar-Kharghan, V.1
Diz-Küçükkaya, R.2
Ludwig, E.H.3
Marian, A.J.4
López, J.A.5
-
79
-
-
5344250943
-
Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction
-
DOI 10.1016/j.ahj.2004.04.020, PII S0002870304002200
-
Roldán, V.; González-Conejero, R.; Marín, F.; Pineda, J.; Vicente, V.; Corral, J. Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction. Am. Heart J., 2004, 148, 602-605. (Pubitemid 39349378)
-
(2004)
American Heart Journal
, vol.148
, Issue.4
, pp. 602-605
-
-
Roldan, V.1
Gonzalez-Conejero, R.2
Marin, F.3
Pineda, J.4
Vicente, V.5
Corral, J.6
-
80
-
-
34147128223
-
The association of P-selectin glycoprotein ligand-1 VNTR polymorphisms with coronary stent restenosis
-
DOI 10.1007/s11239-006-9020-9
-
Ozben, B.; Diz-Kucukkaya, R.; Bilge, A.K.; Hancer, V.S.; Oncul, A. The association of P-selectin glycoprotein ligand-1 VNTR polymorphisms with coronary stent restenosis. J. Thromb. Thrombolysis, 2007, 23, 181-187. (Pubitemid 46564117)
-
(2007)
Journal of Thrombosis and Thrombolysis
, vol.23
, Issue.3
, pp. 181-187
-
-
Ozben, B.1
Diz-Kucukkaya, R.2
Bilge, A.K.3
Hancer, V.S.4
Oncul, A.5
-
81
-
-
10744231640
-
The variable number of tandem repeat polymorphism in the P-selectin glycoprotein ligand-1 gene is not associated with coronary heart disease
-
DOI 10.1007/s00109-003-0459-2
-
Bugert, P.; Hoffmann, M.M.; Winkelmann, B.R.; Vosberg, M.; Jahn, J.; Entelmann, M.; Katus, H.A.; März, W.; Mansmann, U.; Boehm, B.O.; Goerg, S.; Klüter, H. The variable number of tandem repeat polymorphism in the P-selectin glycoprotein ligand-1 gene is not associated with coronary heart disease. J. Mol. Med. (Berl), 2003, 81, 495-501. (Pubitemid 37070202)
-
(2003)
Journal of Molecular Medicine
, vol.81
, Issue.8
, pp. 495-501
-
-
Bugert, P.1
Hoffmann, M.M.2
Winkelmann, B.R.3
Vosberg, M.4
Jahn, J.5
Entelmann, M.6
Katus, H.A.7
Marz, W.8
Mansmann, U.9
Boehm, B.O.10
Goerg, S.11
Kluter, H.12
-
82
-
-
77950562407
-
The adhesion mediated by the P-selectin P-selectin glycoprotein ligand-1 (PSGL-1) couple is stronger for shorter PSGL-1 variants
-
Barbaux, S.; Poirier, O.; Pincet, F.; Hermand, P.; Tiret, L.; Deterre, P. The adhesion mediated by the P-selectin P-selectin glycoprotein ligand-1 (PSGL-1) couple is stronger for shorter PSGL-1 variants. J. Leukoc. Biol., 2010, 87, 727-734.
-
(2010)
J. Leukoc. Biol.
, vol.87
, pp. 727-734
-
-
Barbaux, S.1
Poirier, O.2
Pincet, F.3
Hermand, P.4
Tiret, L.5
Deterre, P.6
-
83
-
-
4744354605
-
Polymorphisms in the P-selectin (CD62P) and P-selectin glycoprotein ligand-1 (PSGL-1) genes and coronary heart disease
-
DOI 10.1515/CCLM.2004.202
-
Bugert, P.; Vosberg, M.; Entelmann, M.; Jahn, J.; Katus, H.A.; Klüter, H. Polymorphisms in the P-selectin (CD62P) and P-selectin glycoprotein ligand-1 (PSGL-1) genes and coronary heart disease. Clin. Chem. Lab. Med., 2004, 42, 997-1004. (Pubitemid 39307388)
-
(2004)
Clinical Chemistry and Laboratory Medicine
, vol.42
, Issue.9
, pp. 997-1004
-
-
Bugert, P.1
Vosberg, M.2
Entelmann, M.3
Jahn, J.4
Katus, H.A.5
Kluter, H.6
-
84
-
-
0036117531
-
Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation
-
DOI 10.1038/nm0402-366
-
Schön, M.P.; Krahn, T.; Schön, M.; Rodriguez, M.L.; Antonicek, H.; Schultz, J.E.; Ludwig, R.J.; Zollner, T.M.; Bischoff, E.; Bremm, K.D.; Schramm, M.; Henninger, K.; Kaufmann, R.; Gollnick, H.P.; Parker, C.M.; Boehncke, W.H. Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat. Med., 2002, 8, 366-372. (Pubitemid 34407031)
-
(2002)
Nature Medicine
, vol.8
, Issue.4
, pp. 366-372
-
-
Schon, M.P.1
Krahn, T.2
Schon, M.3
Rodriguez, M.-L.4
Antonicek, H.5
Schultz, J.E.6
Ludwig, R.J.7
Zollner, T.M.8
Bischoff, E.9
Bremm, K.-D.10
Schramm, M.11
Henninger, K.12
Kaufmann, R.13
Gollnick, H.P.M.14
Parker, C.M.15
Boehncke, W.-H.16
-
85
-
-
0031964458
-
Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectin
-
He, X.Y.; Xu, Z.; Melrose, J.; Mullowney, A.; Vasquez, M.; Queen, C.; Vexler, V.; Klingbeil, C.; Co, M.S.; Berg, E.L. Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E-and P-selectin. J. Immunol., 1998; 160, 1029-1035. (Pubitemid 28049350)
-
(1998)
Journal of Immunology
, vol.160
, Issue.2
, pp. 1029-1035
-
-
He, X.-Y.1
Xu, Z.2
Melrose, J.3
Mullowney, A.4
Vasquez, M.5
Queen, C.6
Vexler, V.7
Klingbeil, C.8
Co, M.S.9
Berg, E.L.10
-
86
-
-
0037112549
-
HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke
-
DOI 10.1161/01.RES.0000042063.15901.20
-
Mocco, J.; Choudhri, T.; Huang, J.; Harfeldt, E.; Efros, L.; Klingbeil, C.; Vexler, V.; Hall, W.; Zhang, Y.; Mack, W.; Popilskis, S.; Pinsky, D.J.; Connolly, E.S. Jr. HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke. Circ. Res., 2002, 91, 907-914. (Pubitemid 35373590)
-
(2002)
Circulation Research
, vol.91
, Issue.10
, pp. 907-914
-
-
Mocco, J.1
Choudhri, T.2
Huang, J.3
Harfeldt, E.4
Efros, L.5
Klingbeil, C.6
Vexler, V.7
Hall, W.8
Zhang, Y.9
Mack, W.10
Popilskis, S.11
Pinsky, D.J.12
Connolly Jr., E.S.13
-
87
-
-
33846922349
-
Microparticle adhesive dynamics and rolling mediated by selectin-specific antibodies under flow
-
DOI 10.1002/bit.21153
-
Ham, A.S.; Goetz, D.J.; Klibanov, A.L.; Lawrence, M.B. Microparticle adhesive dynamics and rolling mediated by selectin-specific antibodies under flow. Biotechnol. Bioeng., 2007, 96, 596-607. (Pubitemid 46232364)
-
(2007)
Biotechnology and Bioengineering
, vol.96
, Issue.3
, pp. 596-607
-
-
Ham, A.S.W.1
Goetz, D.J.2
Klibanov, A.L.3
Lawrence, M.B.4
-
88
-
-
0029839316
-
Effects of E-selectin and P-selectin blockade on neutrophil sequestration in tissues and neutrophil oxidative burst in burned rats
-
Hansbrough, J.F.; Wikström, T.; Braide, M.; Tenenhaus, M.; Rennekampff, O.H.; Kiessig, V.; Zapata-Sirvent, R.; Bjursten, L.M. Effects of E-selectin and P-selectin blockade on neutrophil sequestration in tissues and neutrophil oxidative burst in burned rats. Crit. Care Med., 1996, 24, 1366-1372. (Pubitemid 26262412)
-
(1996)
Critical Care Medicine
, vol.24
, Issue.8
, pp. 1366-1372
-
-
Hansbrough, J.F.1
Wikstrom, T.2
Braide, M.3
Tenenhaus, M.4
Rennekampff, O.H.5
Kiessig, V.6
Zapata-Sirvent, R.7
Bjursten, L.M.8
-
89
-
-
33747172008
-
A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1 via retrograde intracoronary route
-
DOI 10.1161/CIRCULATIONAHA.105.000794, PII 0000301720060704100041
-
Fukushima, S.; Coppen, S.R.; Varela-Carver, A.; Yamahara, K.; Sarathchandra, P.; Smolenski, R.T.; Yacoub, M.H.; Suzuki, K. A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1 via retrograde intracoronary route. Circulation, 2006, 114(1 Suppl), I251-256. (Pubitemid 44297159)
-
(2006)
Circulation
, vol.114
, Issue.SUPPL. 1
-
-
Fukushima, S.1
Coppen, S.R.2
Varela-Carver, A.3
Yamahara, K.4
Sarathchandra, P.5
Smolenski, R.T.6
Yacoub, M.H.7
Suzuki, K.8
-
90
-
-
0037630017
-
Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice
-
DOI 10.1161/01.CIR.0000065604.56839.18
-
Phillips, J.W.; Barringhaus, K.G.; Sanders, J.M.; Hesselbacher, S.E.; Czarnik, A.C.; Manka, D.; Vestweber, D.; Ley, K.; Sarembock, I.J. Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein Edeficient mice. Circulation, 2003, 107, 2244-2249. (Pubitemid 36547220)
-
(2003)
Circulation
, vol.107
, Issue.17
, pp. 2244-2249
-
-
Phillips, J.W.1
Barringhaus, K.G.2
Sanders, J.M.3
Hesselbacher, S.E.4
Czarnik, A.C.5
Manka, D.6
Vestweber, D.7
Ley, K.8
Sarembock, I.J.9
-
91
-
-
33644945725
-
Effect of P-selectin inhibition on leukocyte-endothelium interaction and survival after global cerebral ischemia
-
Lehmberg, J.; Beck, J.; Baethmann, A.; Uhl, E. Effect of P-selectin inhibition on leukocyte-endothelium interaction and survival after global cerebral ischemia. J. Neurol., 2006, 253, 357-363.
-
(2006)
J. Neurol.
, vol.253
, pp. 357-363
-
-
Lehmberg, J.1
Beck, J.2
Baethmann, A.3
Uhl, E.4
-
92
-
-
78650419600
-
P-selectin-mediated plateletneutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease
-
Polanowska-Grabowska, R.; Wallace, K.; Field, J.J.; Chen, L.; Marshall, M.A.; Figler, R.; Gear, A.R.; Linden, J. P-selectin-mediated plateletneutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 2392-2399.
-
(2010)
Arterioscler. Thromb. Vasc. Biol.
, vol.30
, pp. 2392-2399
-
-
Polanowska-Grabowska, R.1
Wallace, K.2
Field, J.J.3
Chen, L.4
Marshall, M.A.5
Figler, R.6
Gear, A.R.7
Linden, J.8
-
93
-
-
29644443259
-
Molecular characterization of rat leukocyte P-selectin glycoprotein ligand-1 and effect of its blockade: Protection from ischemia-reperfusion injury in liver transplantation
-
Tsuchihashi, S.; Fondevila, C.; Shaw, G.D.; Lorenz, M.; Marquette, K.; Benard, S.; Shen, X,D,; Ke, B.; Busuttil, R.W.; Kupiec-Weglinski, J.W. Molecular characterization of rat leukocyte P-selectin glycoprotein ligand-1 and effect of its blockade: Protection from ischemia-reperfusion injury in liver transplantation. J. Immunol., 2006, 176, 616-624. (Pubitemid 43023310)
-
(2006)
Journal of Immunology
, vol.176
, Issue.1
, pp. 616-624
-
-
Tsuchihashi, S.-I.1
Fondevila, C.2
Shaw, G.D.3
Lorenz, M.4
Marquette, K.5
Benard, S.6
Shen, X.-D.7
Ke, B.8
Busuttil, R.W.9
Kupiec-Weglinski, J.W.10
-
94
-
-
79951956172
-
Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge
-
Miszti-Blasius, K.; Debreceni, I.B.; Felszeghy, S.; Dezso, B.; Kappelmayer, J. Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge. Thromb. Res., 2011, 127, 228-234.
-
(2011)
Thromb. Res.
, vol.127
, pp. 228-234
-
-
Miszti-Blasius, K.1
Debreceni, I.B.2
Felszeghy, S.3
Dezso, B.4
Kappelmayer, J.5
-
95
-
-
0035316335
-
Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection
-
Opal, S.M.; Sypek, J.P.; Keith, J.C. Jr.; Schaub, R.G.; Palardy, J.E.; Parejo, N.A. Evaluation of the safety of recombinant P-selectin glycoprotein ligandimmunoglobulin G fusion protein in experimental models of localized and systemic infection. Shock, 2001, 15, 285-290. (Pubitemid 33596720)
-
(2001)
Shock
, vol.15
, Issue.4
, pp. 285-290
-
-
Opal, S.M.1
Sypek, J.P.2
Keith Jr., J.C.3
Schaub, R.G.4
Palardy, J.E.5
Parejo, N.A.6
-
96
-
-
0033574172
-
Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model
-
Kumar, A.; Villani, M.P.; Patel, U.K.; Keith, J.C. Jr.; Schaub, R.G. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation, 1999, 99, 1363-1369. (Pubitemid 29129923)
-
(1999)
Circulation
, vol.99
, Issue.10
, pp. 1363-1369
-
-
Kumar, A.1
Villani, M.P.2
Patel, U.K.3
Keith Jr., J.C.4
Schaub, R.G.5
-
97
-
-
33750019564
-
Selectins -potential pharmacological targets?
-
Kneuer, C.; Ehrhardt, C.; Radomski, M.W.; Bakowsky, U. Selectins -potential pharmacological targets? Drug. Discov. Today, 2006, 11, 1034-1040.
-
(2006)
Drug. Discov. Today
, vol.11
, pp. 1034-1040
-
-
Kneuer, C.1
Ehrhardt, C.2
Radomski, M.W.3
Bakowsky, U.4
-
98
-
-
0035957026
-
Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine
-
Bienvenu, J.G.; Tanguay, J.F.; Théorêt, J.F.; Kumar, A.; Schaub, R.G.; Merhi, Y. Recombinant soluble p-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Circulation, 2001, 103, 1128-1134. (Pubitemid 32200188)
-
(2001)
Circulation
, vol.103
, Issue.8
, pp. 1128-1134
-
-
Bienvenu, J.-G.1
Tanguay, J.-F.2
Theoret, J.-F.3
Kumar, A.4
Schaub, R.G.5
Merhi, Y.6
-
99
-
-
3042622159
-
Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-I
-
Tanguay, J.F.; Geoffroy, P.; Sirois, M.G.; Libersan, D.; Kumar, A.; Schaub, R.G.; Merhi, Y. Prevention of in-stent restenosis via reduction of thromboinflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Thromb. Haemost., 2004, 91, 1186-1193. (Pubitemid 38821276)
-
(2004)
Thrombosis and Haemostasis
, vol.91
, Issue.6
, pp. 1186-1193
-
-
Tanguay, J.F.1
Geoffroy, P.2
Sirois, M.G.3
Libersan, D.4
Kumar, A.5
Schaub, R.G.6
Merhi, Y.7
-
100
-
-
4143135386
-
Evaluation of cardioprotective effects of recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in myocardial ischemia-reperfusion injury by real-time myocardial contrast echocardiography
-
DOI 10.1016/j.jacc.2004.05.052, PII S0735109704011209
-
Hansen, A.; Kumar, A.; Wolf, D.; Frankenbergerova, K.; Filusch, A.; Gross, M.L.; Mueller, S.; Katus, H.; Kuecherer, H. Evaluation of cardioprotective effects of recombinant soluble P-selectin glycoprotein ligandimmunoglobulin in myocardial ischemia-reperfusion injury by real-time myocardial contrast echocardiography. J. Am. Coll. Cardiol., 2004, 44, 887-891. (Pubitemid 39099589)
-
(2004)
Journal of the American College of Cardiology
, vol.44
, Issue.4
, pp. 887-891
-
-
Hansen, A.1
Kumar, A.2
Wolf, D.3
Frankenbergerova, K.4
Filusch, A.5
Gross, M.-L.6
Mueller, S.7
Katus, H.8
Kuecherer, H.9
-
101
-
-
33745642948
-
PSALM investigators. Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial
-
Mertens, P.; Maes, A.; Nuyts, J.; Belmans, A.; Desmet, W.; Esplugas, E.; Charlier, F.; Figueras, J.; Sambuceti, G.; Schwaiger, M.; Mortelmans, L.; Van de Werf, F.; PSALM investigators. Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial. Am. Heart. J., 2006, 152, 125.e1-8.
-
(2006)
Am. Heart. J.
, vol.152
-
-
Mertens, P.1
Maes, A.2
Nuyts, J.3
Belmans, A.4
Desmet, W.5
Esplugas, E.6
Charlier, F.7
Figueras, J.8
Sambuceti, G.9
Schwaiger, M.10
Mortelmans, L.11
Van De Werf, F.12
-
102
-
-
80051689516
-
YSPSL (rPSGL-Ig) for improvement of early renal allograft function: A double-blind, placebo-controlled, multi-center Phase IIa study
-
[Epub ahead of print]
-
Osama Gaber, A.; Mulgaonkar, S.; Kahan, B.D.; Steve Woodle, E.; Alloway, R.; Bajjoka, I.; Jensik, S.; Klintmalm, G.B.; Patton, P.R.; Wiseman, A.; Lipshutz, G.; Kupiec-Weglinski, J.; Gaber, L.W.; Katz, E.; Irish, W.; Squiers, E.C.; Hemmerich, S. YSPSL (rPSGL-Ig) for improvement of early renal allograft function: A double-blind, placebo-controlled, multi-center Phase IIa study. Clin. Transplant., 2011[Epub ahead of print]
-
(2011)
Clin. Transplant.
-
-
Osama Gaber, A.1
Mulgaonkar, S.2
Kahan, B.D.3
Steve Woodle, E.4
Alloway, R.5
Bajjoka, I.6
Jensik, S.7
Klintmalm, G.B.8
Patton, P.R.9
Wiseman, A.10
Lipshutz, G.11
Kupiec-Weglinski, J.12
Gaber, L.W.13
Katz, E.14
Irish, W.15
Squiers, E.C.16
Hemmerich, S.17
-
103
-
-
79953244190
-
RPSGL-Ig for improvement of early liver allograft function: A double-blind, placebo-controlled, single-center phase II study
-
Busuttil, R.W.; Lipshutz, G.S.; Kupiec-Weglinski, J.W.; Ponthieux, S.; Gjertson, D.W.; Cheadle, C.; Watkins, T.; Ehrlich, E.; Katz, E.; Squiers, E.C.; Rabb, H.; Hemmerich, S. rPSGL-Ig for improvement of early liver allograft function: A double-blind, placebo-controlled, single-center phase II study. Am. J. Transplant., 2011, 11, 786-797.
-
(2011)
Am. J. Transplant.
, vol.11
, pp. 786-797
-
-
Busuttil, R.W.1
Lipshutz, G.S.2
Kupiec-Weglinski, J.W.3
Ponthieux, S.4
Gjertson, D.W.5
Cheadle, C.6
Watkins, T.7
Ehrlich, E.8
Katz, E.9
Squiers, E.C.10
Rabb, H.11
Hemmerich, S.12
-
104
-
-
26644446210
-
Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury
-
DOI 10.1097/01.TP.0000174337.53658.B0
-
Farmer, D.G.; Anselmo, D.; Da Shen, X.; Ke, B.; Carmody, I.C.; Gao, F.; Lassman, C.; McDiarmid, S.V.; Shaw, G.; Busuttil, R.W.; Kupiec-Weglinski, J.W. Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury. Transplantation, 2005, 80, 828-835. (Pubitemid 41443767)
-
(2005)
Transplantation
, vol.80
, Issue.6
, pp. 828-835
-
-
Farmer, D.G.1
Anselmo, D.2
Shen, X.D.3
Ke, B.4
Carmody, I.C.5
Gao, F.6
Lassman, C.7
McDiarmid, S.V.8
Shaw, G.9
Busuttil, R.W.10
Kupiec-Weglinski, J.W.11
-
105
-
-
1842611762
-
P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA/1 mice partly through the suppression of tumour necrosis factor
-
DOI 10.1111/j.1365-2249.2004.02421.x
-
Sumariwalla, P.F.; Malfait, A.M.; Feldmann, M. P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA/1 mice partly through the suppression of tumour necrosis factor. Clin. Exp. Immunol., 2004, 136, 67-75. (Pubitemid 38437767)
-
(2004)
Clinical and Experimental Immunology
, vol.136
, Issue.1
, pp. 67-75
-
-
Sumariwalla, P.F.1
Malfait, A.M.2
Feldmann, M.3
-
106
-
-
0036846759
-
x mimics as E- and P-selectin inhibitors
-
DOI 10.1002/med.10018
-
Kaila, N.; Thomas, B.E. 4th. Design and synthesis of sialyl Lewis(x) mimics as E-and P-selectin inhibitors. Med. Res. Rev., 2002, 22, 566-601. (Pubitemid 35299534)
-
(2002)
Medicinal Research Reviews
, vol.22
, Issue.6
, pp. 566-601
-
-
Kaila, N.1
Thomas IV, B.E.2
-
107
-
-
14444268539
-
Novel synthetic inhibitors of selectin-mediated cell adhesion: Synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)phenyl] hexane (TBC1269)
-
DOI 10.1021/jm9704917
-
Kogan, T.P.; Dupré, B.; Bui, H.; McAbee, K.L.; Kassir, J.M.; Scott, I.L.; Hu, X.; Vanderslice, P.; Beck, P.J.; Dixon, R.A. Novel synthetic inhibitors of selectin-mediated cell adhesion: Synthesis of 1,6-bis[3-(3- carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyloxy)phenyl]hexane (TBC1269). J. Med. Chem., 1998, 41, 1099-1111. (Pubitemid 28207386)
-
(1998)
Journal of Medicinal Chemistry
, vol.41
, Issue.7
, pp. 1099-1111
-
-
Kogan, T.P.1
Dupre, B.2
Bui, H.3
McAbee, K.L.4
Kassir, J.M.5
Scott, I.L.6
Hu, X.7
Vanderslice, P.8
Beck, P.J.9
Dixon, R.A.F.10
-
108
-
-
0037904051
-
Development of synthetic pan-selectin antagonists: A new treatment strategy for chronic inflammation in asthma
-
DOI 10.1159/000070746
-
Aydt, E.; Wolff, G. Development of synthetic pan-selectin antagonists: A new treatment strategy for chronic inflammation in asthma. Pathobiology, 2003, 70, 297-301. (Pubitemid 36682978)
-
(2002)
Pathobiology
, vol.70
, Issue.5
, pp. 297-301
-
-
Aydt, E.1
Wolff, G.2
-
109
-
-
26844541696
-
Physiochemical properties, safety and pharmacokinetics of bimosiamose disodium after intravenous administration
-
Meyer, M.; Jilma, B.; Zahlten, R.; Wolff, G. Physiochemical properties, safety and pharmacokinetics of bimosiamose disodium after intravenous administration. Int. J. Clin. Pharmacol. Ther., 2005, 43, 463-471. (Pubitemid 41448420)
-
(2005)
International Journal of Clinical Pharmacology and Therapeutics
, vol.43
, Issue.10
, pp. 463-471
-
-
Meyer, M.1
Jilma, B.2
Zahlten, R.3
Wolff, G.4
-
110
-
-
0344827160
-
Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischemia/reperfusion injury
-
DOI 10.1016/j.ejphar.2003.09.040
-
Onai, Y.; Suzuki, J.; Nishiwaki, Y.; Gotoh, R.; Berens, K.; Dixon, R.; Yoshida, M.; Ito, H.; Isobe, M. Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischemia/reperfusion injury. Eur. J. Pharmacol., 2003, 481, 217-225. (Pubitemid 37464973)
-
(2003)
European Journal of Pharmacology
, vol.481
, Issue.2-3
, pp. 217-225
-
-
Onai, Y.1
Suzuki, J.-I.2
Nishiwaki, Y.3
Gotoh, R.4
Berens, K.5
Dixon, R.6
Yoshida, M.7
Ito, H.8
Isobe, M.9
-
111
-
-
33645324424
-
Bimosiamose an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: A randomized, double-blind, placebo-controlled clinical cross-over-trial
-
Beeh, K.M.; Beier, J.; Meyer, M.; Buhl, R.; Zahlten, R.; Wolff, G. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: A randomized, double-blind, placebo-controlled clinical cross-over-trial. Pulm. Pharmacol. Ther., 2006, 19, 233-241.
-
(2006)
Pulm. Pharmacol. Ther.
, vol.19
, pp. 233-241
-
-
Beeh, K.M.1
Beier, J.2
Meyer, M.3
Buhl, R.4
Zahlten, R.5
Wolff, G.6
-
112
-
-
80052395355
-
Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects -A double blind, randomized, placebo-controlled, cross-over clinical trial
-
[Epub ahead of print]
-
Kirsten, A.; Watz, H.; Kretschmar, G.; Pedersen, F.; Bock, D.; Meyer-Sabellek, W.; Magnussen, H. Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects -A double blind, randomized, placebo-controlled, cross-over clinical trial. Pulm. Pharmacol. Ther., 2011[Epub ahead of print]
-
(2011)
Pulm. Pharmacol. Ther.
-
-
Kirsten, A.1
Watz, H.2
Kretschmar, G.3
Pedersen, F.4
Bock, D.5
Meyer-Sabellek, W.6
Magnussen, H.7
-
113
-
-
31344431570
-
Pan-selectin antagonism improves psoriasis manifestation in mice and man
-
DOI 10.1007/s00403-005-0626-0
-
Friedrich, M.; Bock, D.; Philipp, S.; Ludwig, N.; Sabat, R.; Wolk, K.; Schroeter-Maas, S.; Aydt, E.; Kang, S.; Dam, T.N.; Zahlten, R.; Sterry, W.; Wolff, G. Pan-selectin antagonism improves psoriasis manifestation in mice and man. Arch. Dermatol. Res., 2006, 297, 345-351. (Pubitemid 43144265)
-
(2006)
Archives of Dermatological Research
, vol.297
, Issue.8
, pp. 345-351
-
-
Friedrich, M.1
Bock, D.2
Philipp, S.3
Ludwig, N.4
Sabat, R.5
Wolk, K.6
Schroeter-Maas, S.7
Aydt, E.8
Kang, S.9
Dam, T.N.10
Zahlten, R.11
Sterry, W.12
Wolff, G.13
-
114
-
-
40949086098
-
Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia
-
DOI 10.1097/SHK.0b013e318142c4e8, PII 0002438220080400000009
-
Mayr, F.B.; Firbas, C.; Leitner, J.M.; Spiel, A.O.; Reiter, R.A.; Beyer, D.; Meyer, M.; Wolff, G.; Jilma, B. Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia. Shock, 2008, 29, 475-482. (Pubitemid 351416801)
-
(2008)
Shock
, vol.29
, Issue.4
, pp. 475-482
-
-
Mayr, F.B.1
Firbas, C.2
Leitner, J.M.3
Spiel, A.O.4
Reiter, R.A.5
Beyer, D.6
Meyer, M.7
Wolff, G.8
Jilma, B.9
-
115
-
-
16644369039
-
Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines
-
DOI 10.1097/01.ASN.0000142425.23036.AC
-
Langer, R.; Wang, M.; Stepkowski, S.M.; Hancock, W.W.; Han, R.; Li, P.; Feng, L.; Kirken, R.A.; Berens, K.L.; Dupre, B.; Podder, H.; Dixon, R.A.; Kahan, B.D. Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines. J. Am. Soc. Nephrol., 2004, 15, 2893-2901. (Pubitemid 41103398)
-
(2004)
Journal of the American Society of Nephrology
, vol.15
, Issue.11
, pp. 2893-2901
-
-
Langer, R.1
Wang, M.2
Stepkowski, S.M.3
Hancock, W.W.4
Han, R.5
Li, P.6
Feng, L.7
Kirken, R.A.8
Berens, K.L.9
Dupre, B.10
Podder, H.11
Dixon, R.A.F.12
Kahan, B.D.13
-
116
-
-
0033623863
-
Sialyl Lewis(X) oligosaccharide preserves cardiopulmonary and endothelial function after hypothermic circulatory arrest in lambs
-
Schermerhorn, M.L.; Tofukuji, M.; Khoury, P.R.; Phillips, L.; Hickey, P.R.; Sellke, F.W.; Mayer, J.E. Jr.; Nelson, D.P. Sialyl lewis oligosaccharide preserves cardiopulmonary and endothelial function after hypothermic circulatory arrest in lambs. J. Thorac. Cardiovasc. Surg., 2000, 120, 230-237. (Pubitemid 30640728)
-
(2000)
Journal of Thoracic and Cardiovascular Surgery
, vol.120
, Issue.2
, pp. 230-237
-
-
Schermerhorn, M.L.1
Tofukuji, M.2
Khoury, P.R.3
Phillips, L.4
Hickey, P.R.5
Sellke, F.W.6
Mayer Jr., J.E.7
Nelson, D.P.8
-
117
-
-
0034264434
-
Sialyl LewisX oligosaccharide preserves myocardial and endothelial function during cardioplegic ischemia
-
Schermerhorn, M.L.; Nelson, D.P.; Blume, E.D.; Phillips, L.; Mayer, J.E. Jr. Sialyl LewisX oligosaccharide preserves myocardial and endothelial function during cardioplegic ischemia. Ann. Thorac. Surg., 2000, 70, 890-894.
-
(2000)
Ann. Thorac. Surg.
, vol.70
, pp. 890-894
-
-
Schermerhorn, M.L.1
Nelson, D.P.2
Blume, E.D.3
Phillips, L.4
Mayer Jr., J.E.5
-
118
-
-
0033928049
-
The use of Cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy
-
Kerr, K.M.; Auger, W.R.; Marsh, J.J.; Comito, R.M.; Fedullo, R.L.; Smits, G.J.; Kapelanski, D.P.; Fedullo, P.F.; Channick, R.N.; Jamieson, S.W.; Moser, K.M. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. Am. J. Respir. Crit. Care Med., 2000, 162, 14-20. (Pubitemid 30469791)
-
(2000)
American Journal of Respiratory and Critical Care Medicine
, vol.162
, Issue.1
, pp. 14-20
-
-
Kerr, K.M.1
Auger, W.R.2
Marsh, J.J.3
Comito, R.M.4
Fedullo, R.L.5
Smits, G.J.6
Kapelanski, D.P.7
Fedullo, P.F.8
Channick, R.N.9
Jamieson, S.W.10
Moser, K.M.11
-
119
-
-
0035205557
-
Inhibition of P-selectin specific cell adhesion by a low molecular weight, non-carbohydrate compound, KF38789
-
Ohta, S.; Inujima, Y.; Abe, M.; Uosaki, Y.; Sato, S.; Miki, I. Inhibition of Pselectin specific cell adhesion by a low molecular weight, non-carbohydrate compound, KF38789. Inflamm. Res., 2001, 50, 544-551. (Pubitemid 33121901)
-
(2001)
Inflammation Research
, vol.50
, Issue.11
, pp. 544-551
-
-
Ohta, S.1
Inujima, Y.2
Abe, M.3
Uosaki, Y.4
Sato, S.5
Miki, I.6
-
120
-
-
0014415942
-
The release of platelet factor 4 during platelet aggregation and the possible significance of this reaction in hemostasis
-
Niewiarowski, S.; Lipiski, B.; Farbiszewski, R.; Poplawski, A. The release of platelet factor 4 during platelet aggregation and the possible significance of this reaction in hemostasis. Experientia, 1968, 24, 343-344.
-
(1968)
Experientia
, vol.24
, pp. 343-344
-
-
Niewiarowski, S.1
Lipiski, B.2
Farbiszewski, R.3
Poplawski, A.4
-
121
-
-
0023185484
-
Human platelet factor 4 gene is mapped to 4q12-q21
-
Griffin, C.A.; Emanuel, B.S.; LaRocco, P.; Schwartz, E.; Poncz, M. Human platelet factor 4 gene is mapped to 4q12-q21. Cytogenet. Cell. Genet., 1987, 45, 67-69. (Pubitemid 17123207)
-
(1987)
Cytogenetics and Cell Genetics
, vol.45
, Issue.2
, pp. 67-69
-
-
Griffin, C.A.1
Emanuel, B.S.2
LaRocco, P.3
-
122
-
-
0028064302
-
Crystal structure of recombinant human platelet factor 4
-
DOI 10.1021/bi00193a025
-
Zhang, X.; Chen, L.; Bancroft, D.P.; Lai, C.K.; Maione, T.E. Crystal structure of recombinant human platelet factor 4. Biochemistry, 1994, 33, 8361-8366. (Pubitemid 24241072)
-
(1994)
Biochemistry
, vol.33
, Issue.27
, pp. 8361-8366
-
-
Zhang, X.1
Chen, L.2
Bancroft, D.P.3
Lai, C.K.4
Maione, T.E.5
-
123
-
-
22144494616
-
Regulated expression of platelet factor 4 in human monocytes - Role of PARs as a quantitatively important monocyte activation pathway
-
DOI 10.1189/jlb.0105024
-
Schaffner, A.; Rhyn, P.; Schoedon, G.; Schaer, D.J. Regulated expression of platelet factor 4 in human monocytes -role of PARs as a quantitatively important monocyte activation pathway. J. Leukoc. Biol., 2005, 78, 202-209. (Pubitemid 40979959)
-
(2005)
Journal of Leukocyte Biology
, vol.78
, Issue.1
, pp. 202-209
-
-
Schaffner, A.1
Rhyn, P.2
Schoedon, G.3
Schaer, D.J.4
-
124
-
-
0020959863
-
The immunoelectronmicroscopic localization of human platelet factor 4 in tissue mast cells
-
McLaren, K.M.; Pepper, D.S. The immunoelectronmicroscopic localization of human platelet factor 4 in tissue mast cells. Histochem. J., 1983, 15, 795-800. (Pubitemid 13047742)
-
(1983)
Histochemical Journal
, vol.15
, Issue.8
, pp. 795-800
-
-
McLaren, K.M.1
Pepper, D.S.2
-
125
-
-
77954944628
-
Normal ranges of angiogenesis regulatory proteins in human platelets
-
Peterson, J.E.; Zurakowski, D.; Italiano, J.E. Jr., Michel, L.V.; Fox, L.; Klement, G.L.; Folkman, J. Normal ranges of angiogenesis regulatory proteins in human platelets. Am. J. Hematol., 2010, 85, 487-493.
-
(2010)
Am. J. Hematol.
, vol.85
, pp. 487-493
-
-
Peterson, J.E.1
Zurakowski, D.2
Italiano Jr., J.E.3
Michel, L.V.4
Fox, L.5
Klement, G.L.6
Folkman, J.7
-
126
-
-
0033652243
-
Platelet-derived CXC chemokines: Old players in new games
-
Brandt, E.; Ludwig, A.; Petersen, F.; Flad, H.D. Platelet-derived CXC chemokines: Old players in new games. Immunol. Rev., 2000, 177, 204-216.
-
(2000)
Immunol. Rev.
, vol.177
, pp. 204-216
-
-
Brandt, E.1
Ludwig, A.2
Petersen, F.3
Flad, H.D.4
-
127
-
-
0018150232
-
Plasma levels of platelet factor 4 measured by radioimmunoassay
-
Chesterman, C.N.; McGready, J.R.; Doyle, D.J.; Morgan, F.J. Plasma levels of platelet factor 4 measured by radioimmunoassay. Br. J. Haematol., 1978, 40, 489-500. (Pubitemid 9027683)
-
(1978)
British Journal of Haematology
, vol.40
, Issue.3
, pp. 489-500
-
-
Chesterman, C.N.1
McGready, J.R.2
Doyle, D.J.3
Morgan, F.J.4
-
128
-
-
0347043610
-
Platelet factor 4 localization in carotid atherosclerotic plaques: Correlation with clinical parameters
-
Pitsilos, S.; Hunt, J.; Mohler, E.R.; Prabhakar, A.M.; Poncz, M.; Dawicki, J.; Khalapyan, T.Z.; Wolfe, M.L.; Fairman, R.; Mitchell, M.; Carpenter, J.; Golden, M.A.; Cines, D.B.; Sachais, B.S. Platelet factor 4 localization in carotid atherosclerotic plaques: Correlation with clinical parameters. Thromb. Haemost., 2003, 90, 1112-1120. (Pubitemid 38004432)
-
(2003)
Thrombosis and Haemostasis
, vol.90
, Issue.6
, pp. 1112-1120
-
-
Pitsilos, S.1
Hunt, J.2
Mohler, E.R.3
Prabhakar, A.M.4
Poncz, M.5
Dawicki, J.6
Khalapyan, T.Z.7
Wolfe, M.L.8
Fairman, R.9
Mitchell, M.10
Carpenter, J.11
Golden, M.A.12
Cines, D.B.13
Sachais, B.S.14
-
129
-
-
3843100374
-
Interactions of platelet factor 4 with the vessel wall
-
DOI 10.1055/s-2004-831048
-
Sachais, B.S.; Higazi, A.A.; Cines, D.B.; Poncz, M.; Kowalska, M.A. Interactions of platelet factor 4 with the vessel wall. Semin. Thromb. Hemost., 2004, 30, 351-358. (Pubitemid 39037629)
-
(2004)
Seminars in Thrombosis and Hemostasis
, vol.30
, Issue.3
, pp. 351-358
-
-
Sachais, B.S.1
Higazi, A.A.-R.2
Cines, D.B.3
Poncz, M.4
Kowalska, M.A.5
-
130
-
-
0018649114
-
Antiheparin proteins secreted by human platelets. Purification, characterization and radioimmunoassay
-
Rucinski, B.; Niewiarowski, S.; James, P.; Walz, D.A.; Budzynski, A.Z. Antiheparin proteins secreted by human platelets. Purification, characterization, and radioimmunoassay. Blood, 1979, 53, 47-62. (Pubitemid 9079257)
-
(1979)
Blood
, vol.53
, Issue.1
, pp. 47-62
-
-
Rucinski, B.1
Niewiarowski, S.2
James, P.3
-
131
-
-
77549083170
-
The prothrombotic potential of platelet factor 4
-
Thachil, J. The prothrombotic potential of platelet factor 4. Eur. J. Intern. Med., 2010, 21, 79-83.
-
(2010)
Eur. J. Intern. Med.
, vol.21
, pp. 79-83
-
-
Thachil, J.1
-
132
-
-
3843072270
-
Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: Dissociation between anticoagulant and antithrombotic effect of heparin
-
DOI 10.1182/blood-2003-11-3994
-
Eslin, D.E.; Zhang, C.; Samuels, K.J.; Rauova, L.; Zhai, L.; Niewiarowski, S.; Cines, D.B.; Poncz, M.; Kowalska, M.A. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: Dissociation betweenanticoagulant and antithrombotic effect of heparin. Blood, 2004, 104, 3173-3180. (Pubitemid 39507132)
-
(2004)
Blood
, vol.104
, Issue.10
, pp. 3173-3180
-
-
Eslin, D.E.1
Zhang, C.2
Samuels, K.J.3
Rauova, L.4
Zhai, L.5
Niewiarowski, S.6
Cines, D.B.7
Poncz, M.8
Kowalska, M.A.9
-
133
-
-
0028113453
-
Platelet factor 4 stimulates thrombomodulin protein C-activating cofactor activity. A structure-function analysis
-
Slungaard, A.; Key, N.S. Platelet factor 4 stimulates thrombomodulin protein C-activating cofactor activity. A structure-function analysis. J. Biol. Chem., 1994, 269, 25549-25556.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 25549-25556
-
-
Slungaard, A.1
Key, N.S.2
-
134
-
-
65549096799
-
Platelet factor 4 impairs the anticoagulant activity of activated protein C
-
Preston, R.J.; Tran, S.; Johnson, J.A.; Ní Áinle, F.; Harmon, S.; White, B.; Smith, O.P.; Jenkins, P.V.; Dahlbäck, B.; O'Donnell, J.S. Platelet factor 4 impairs the anticoagulant activity of activated protein C. J. Biol. Chem., 2009, 284, 5869-5875.
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 5869-5875
-
-
Preston, R.J.1
Tran, S.2
Johnson, J.A.3
Ní Áinle, F.4
Harmon, S.5
White, B.6
Smith, O.P.7
Jenkins, P.V.8
Dahlbäck, B.9
O'Donnell, J.S.10
-
135
-
-
12444260282
-
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4
-
DOI 10.1084/jem.20021897
-
Lasagni, L.; Francalanci, M.; Annunziato, F.; Lazzeri, E.; Giannini, S.; Cosmi, L.; Sagrinati, C.; Mazzinghi, B.; Orlando, C.; Maggi, E.; Marra, F.; Romagnani, S.; Serio, M.; Romagnani, P. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med., 2003, 197, 1537-1549. (Pubitemid 36682550)
-
(2003)
Journal of Experimental Medicine
, vol.197
, Issue.11
, pp. 1537-1549
-
-
Lasagni, L.1
Francalanci, M.2
Annunziato, F.3
Lazzeri, E.4
Giannini, S.5
Cosmi, L.6
Sagrinati, C.7
Mazzinghi, B.8
Orlando, C.9
Maggi, E.10
Marra, F.11
Romagnani, S.12
Serio, M.13
Romagnani, P.14
-
136
-
-
0033617381
-
Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4
-
Petersen, F.; Brandt, E.; Lindahl, U.; Spillmann, D. Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4. J. Biol. Chem., 1999, 274, 12376-12382.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 12376-12382
-
-
Petersen, F.1
Brandt, E.2
Lindahl, U.3
Spillmann, D.4
-
137
-
-
12844273413
-
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
-
DOI 10.1182/blood-2004-06-2475
-
von Hundelshausen, P.; Koenen, R.R.; Sack, M.; Mause, S.F.; Adriaens, W.; Proudfoot, A.E.; Hackeng, T.M.; Weber, C. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood, 2005, 105, 924-930. (Pubitemid 40170856)
-
(2005)
Blood
, vol.105
, Issue.3
, pp. 924-930
-
-
Von Hundelshausen, P.1
Koenen, R.R.2
Sack, M.3
Mause, S.F.4
Adriaens, W.5
Proudfoot, A.E.I.6
Hackeng, T.M.7
Weber, C.8
-
138
-
-
0034651633
-
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages
-
Scheuerer, B.; Ernst, M.; Dürrbaum-Landmann, I.; Fleischer, J.; Grage-Griebenow, E.; Brandt, E.; Flad, H.D.; Petersen, F. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood, 2000, 95, 1158-1166. (Pubitemid 30099821)
-
(2000)
Blood
, vol.95
, Issue.4
, pp. 1158-1166
-
-
Scheuerer, B.1
Ernst, M.2
Durrbaum-Landmann, I.3
Fleischer, J.4
Grage-Griebenow, E.5
Brandt, E.6
Flad, H.-D.7
Petersen, F.8
-
139
-
-
0034102501
-
Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis
-
Vrij, A.A.; Rijken, J.; Van Wersch, J.W.; Stockbrügger, R.W. Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur. J. Clin. Invest., 2000, 30, 188-1894.
-
(2000)
Eur. J. Clin. Invest.
, vol.30
, pp. 188-1894
-
-
Vrij, A.A.1
Rijken, J.2
Van Wersch, J.W.3
Stockbrügger, R.W.4
-
140
-
-
0029792718
-
The chemokines: Their potential role in allergic inflammation
-
Teran, L.M.; Davies, D.E. The chemokines: Their potential role in allergic inflammation. Clin. Exp. Allergy., 1996, 26, 1005-1009.
-
(1996)
Clin. Exp. Allergy.
, vol.26
, pp. 1005-1009
-
-
Teran, L.M.1
Davies, D.E.2
-
141
-
-
0037458650
-
Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells
-
DOI 10.1074/jbc.M208894200
-
Nassar, T.; Sachais, B.S.; Akkawi, S.; Kowalska, M.A.; Bdeir, K.; Leitersdorf, E.; Hiss, E.; Ziporen, L.; Aviram, M.; Cines, D.; Poncz, M.; Higazi, A.A. Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J. Biol. Chem., 2003, 278, 6187-6193. (Pubitemid 36800873)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.8
, pp. 6187-6193
-
-
Nassar, T.1
Sachais, B.S.2
Akkawi, S.3
Kowalska, M.A.4
Bdeir, K.5
Leitersdorf, E.6
Hiss, E.7
Ziporen, L.8
Aviram, M.9
Cines, D.10
Poncz, M.11
Higazi, A.A.-R.12
-
142
-
-
0037093278
-
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
-
DOI 10.1182/blood.V99.10.3613
-
Sachais, B.S.; Kuo, A.; Nassar, T.; Morgan, J.; Kariko, K.; Williams, K.J.; Feldman, M.; Aviram, M.; Shah, N.; Jarett, L.; Poncz, M.; Cines, D.B.; Higazi, A.A. Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface. Blood, 2002, 99, 3613-3622. (Pubitemid 34534530)
-
(2002)
Blood
, vol.99
, Issue.10
, pp. 3613-3622
-
-
Sachais, B.S.1
Kuo, A.2
Nassar, T.3
Morgan, J.4
Kariko, K.5
Williams, K.J.6
Feldman, M.7
Aviram, M.8
Shah, N.9
Jarett, L.10
Poncz, M.11
Cines, D.B.12
Higazi, A.A.-R.13
-
143
-
-
0021712457
-
Platelet aggregation, β-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy
-
Fritschi, J.; Christe, M.; Lämmle, B.; Marbet, G.A.; Berger, W.; Duckert, F. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy. Thromb. Haemost., 1984, 52, 236-239. (Pubitemid 15156394)
-
(1984)
Thrombosis and Haemostasis
, vol.52
, Issue.3
, pp. 236-239
-
-
Fritschi, J.1
Christe, M.2
Marbet, G.A.3
-
144
-
-
0026766903
-
Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils
-
Kameyoshi, Y.; Dörschner, A.; Mallet, A.I.; Christophers, E.; Schröder, J.M. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med., 1992, 176, 587-592.
-
(1992)
J. Exp. Med.
, vol.176
, pp. 587-592
-
-
Kameyoshi, Y.1
Dörschner, A.2
Mallet, A.I.3
Christophers, E.4
Schröder, J.M.5
-
145
-
-
0035799376
-
RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium
-
von Hundelshausen, P.; Weber, K.S.; Huo, Y.; Proudfoot, A.E.; Nelson, P.J.; Ley, K.; Weber, C. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation, 2001, 103, 1772-1777. (Pubitemid 32291415)
-
(2001)
Circulation
, vol.103
, Issue.13
, pp. 1772-1777
-
-
Von Hundelshausen, P.1
Weber, K.S.C.2
Huo, Y.3
Proudfoot, A.E.I.4
Nelson, P.J.5
Ley, K.6
Weber, C.7
-
146
-
-
0037126048
-
Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury
-
Schober, A.; Manka, D.; von Hundelshausen, P.; Huo, Y.; Hanrath, P.; Sarembock, I.J.; Ley, K,; Weber, C. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation, 2002, 106, 1523-1529.
-
(2002)
Circulation
, vol.106
, pp. 1523-1529
-
-
Schober, A.1
Manka, D.2
Von Hundelshausen, P.3
Huo, Y.4
Hanrath, P.5
Sarembock, I.J.6
Ley, K.7
Weber, C.8
-
147
-
-
0034672366
-
Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets
-
Clemetson, K.J.; Clemetson, J.M.; Proudfoot, A.E.I.; Power, C.A.; Baggiolini, M.; Wells, T.N.C. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood, 2000, 96, 4046-4054.
-
(2000)
Blood
, vol.96
, pp. 4046-4054
-
-
Clemetson, K.J.1
Clemetson, J.M.2
Proudfoot, A.E.I.3
Power, C.A.4
Baggiolini, M.5
Wells, T.N.C.6
-
148
-
-
0141679065
-
Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium
-
DOI 10.1182/blood-2003-04-1175
-
Baltus, T.; Weber, K.S.; Johnson, Z.; Proudfoot, A.E.; Weber, C. Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood, 2003, 102, 1985-1988. (Pubitemid 37122370)
-
(2003)
Blood
, vol.102
, Issue.6
, pp. 1985-1988
-
-
Baltus, T.1
Weber, K.S.C.2
Johnson, Z.3
Proudfoot, A.E.I.4
Weber, C.5
-
149
-
-
77949567308
-
Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis
-
Kowalska, M.A.; Rauova, L.; Poncz, M. Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. Thromb. Res., 2010, 125, 292-296.
-
(2010)
Thromb. Res.
, vol.125
, pp. 292-296
-
-
Kowalska, M.A.1
Rauova, L.2
Poncz, M.3
-
150
-
-
36048981326
-
-/- mice
-
DOI 10.1160/TH07-04-0271
-
Sachais, B.S.; Turrentine, T.; Dawicki McKenna, J.M.; Rux, A.H.; Rader, D.; Kowalska, M.A. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/-mice. Thromb. Haemost., 2007, 98, 1108-1113. (Pubitemid 350091140)
-
(2007)
Thrombosis and Haemostasis
, vol.98
, Issue.5
, pp. 1108-1113
-
-
Sachais, B.S.1
Turrentine, T.2
McKenna, J.M.D.3
Rux, A.H.4
Rader, D.5
Kowalska, M.A.6
-
151
-
-
58149336758
-
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice
-
Koenen, R.R.; von Hundelshausen, P.; Nesmelova, I.V.; Zernecke, A.; Liehn, E.A.; Sarabi, A.; Kramp, B.K.; Piccinini, A.M.; Paludan, S.R.; Kowalska, M.A.; Kungl, A.J.; Hackeng, T.M.; Mayo, K.H.; Weber, C. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat. Med., 2009, 15, 97-103.
-
(2009)
Nat. Med.
, vol.15
, pp. 97-103
-
-
Koenen, R.R.1
Von Hundelshausen, P.2
Nesmelova, I.V.3
Zernecke, A.4
Liehn, E.A.5
Sarabi, A.6
Kramp, B.K.7
Piccinini, A.M.8
Paludan, S.R.9
Kowalska, M.A.10
Kungl, A.J.11
Hackeng, T.M.12
Mayo, K.H.13
Weber, C.14
-
152
-
-
0037452728
-
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines
-
DOI 10.1073/pnas.0334864100
-
Proudfoot, A.E.; Handel, T.M.; Johnson, Z.; Lau, E.K.; LiWang, P.; Clark-Lewis, I.; Borlat, F.; Wells, T,N.; Kosco-Vilbois, M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA, 2003, 100, 1885-1890. (Pubitemid 36254543)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.4
, pp. 1885-1890
-
-
Proudfoot, A.E.I.1
Handel, T.M.2
Johnson, Z.3
Lau, E.K.4
LiWang, P.5
Clark-Lewis, I.6
Borlat, F.7
Wells, T.N.C.8
Kosco-Vilbois, M.H.9
-
153
-
-
79952105905
-
Heterophilic chemokine receptor interactions in chemokine signaling and biology
-
Kramp, B.K.; Sarabi, A.; Koenen, R.R.; Weber, C. Heterophilic chemokine receptor interactions in chemokine signaling and biology. Exp. Cell. Res., 2011, 317, 655-663.
-
(2011)
Exp. Cell. Res.
, vol.317
, pp. 655-663
-
-
Kramp, B.K.1
Sarabi, A.2
Koenen, R.R.3
Weber, C.4
-
154
-
-
0030022954
-
Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist
-
DOI 10.1074/jbc.271.5.2599
-
Proudfoot, A.E.; Power, C.A.; Hoogewerf, A.J.; Montjovent, M.O.; Borlat, F.; Offord, R.E.; Wells, T.N. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J. Biol. Chem., 1996, 271, 2599-2603. (Pubitemid 26047869)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.5
, pp. 2599-2603
-
-
Proudfoot, A.E.I.1
Power, C.A.2
Hoogewerf, A.J.3
Montjovent, M.-O.4
Borlat, F.5
Offord, R.E.6
Wells, T.N.C.7
-
155
-
-
1042291188
-
Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice
-
DOI 10.1161/01.RES.0000109793.17591.4E
-
Veillard, N.R.; Kwak, B.; Pelli, G.; Mulhaupt, F.; James, R.W.; Proudfoot, A.E.; Mach, F. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ. Res., 2004, 94, 253-261. (Pubitemid 38197459)
-
(2004)
Circulation Research
, vol.94
, Issue.2
, pp. 253-261
-
-
Veillard, N.R.1
Kwak, B.2
Pelli, G.3
Mulhaupt, F.4
James, R.W.5
Proudfoot, A.E.I.6
Mach, F.7
-
156
-
-
33846404914
-
Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice
-
DOI 10.1161/01.ATV.0000253886.44609.ae, PII 0004360520070200000019
-
Braunersreuther, V.; Zernecke, A.; Arnaud, C.; Liehn, E.A.; Steffens, S.; Shagdarsuren, E.; Bidzhekov, K.; Burger, F.; Pelli, G.; Luckow, B.; Mach, F.; Weber, C. Ccr5 but not Ccr1 deficiency reduces development of dietinduced atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol., 2007, 27, 373-379. (Pubitemid 46143054)
-
(2007)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.27
, Issue.2
, pp. 373-379
-
-
Braunersreuther, V.1
Zernecke, A.2
Arnaud, C.3
Liehn, E.A.4
Steffens, S.5
Shagdarsuren, E.6
Bidzhekov, K.7
Burger, F.8
Pelli, G.9
Luckow, B.10
Mach, F.11
Weber, C.12
-
157
-
-
21544460952
-
Platelet microparticles: A transcellular delivery system for RANTES promoting monocyte recruitment on endothelium
-
DOI 10.1161/01.ATV.0000170133.43608.37
-
Mause, S.F.; von Hundelshausen, P.; Zernecke, A.; Koenen, R.R.; Weber, C. Platelet microparticles: A transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 1512-1518. (Pubitemid 40923377)
-
(2005)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.25
, Issue.7
, pp. 1512-1518
-
-
Mause, S.F.1
Von Hundelshausen, P.2
Zernecke, A.3
Koenen, R.R.4
Weber, C.5
-
158
-
-
0036201563
-
Impaired T cell function in RANTES-deficient mice
-
DOI 10.1006/clim.2001.5178
-
Makino, Y.; Cook, D.N.; Smithies, O.; Hwang, O.Y.; Neilson, E.G.; Turka, L.A.; Sato, H.; Wells, A.D.; Danoff, T.M. Impaired T cell function in RANTES-deficient mice. Clin. Immunol., 2002, 102, 302-309. (Pubitemid 34259264)
-
(2002)
Clinical Immunology
, vol.102
, Issue.3
, pp. 302-309
-
-
Makino, Y.1
Cook, D.N.2
Smithies, O.3
Hwang, O.Y.4
Neilson, E.G.5
Turka, L.A.6
Sato, H.7
Wells, A.D.8
Danoff, T.M.9
-
159
-
-
70350447306
-
The multi-functionality of CD40L and its receptor CD40 in atherosclerosis
-
Lievens, D.; Eijgelaar, W.J.; Biessen, E.A.; Daemen, M.J.; Lutgens, E. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb. Haemost., 2009, 102, 206-214.
-
(2009)
Thromb. Haemost.
, vol.102
, pp. 206-214
-
-
Lievens, D.1
Eijgelaar, W.J.2
Biessen, E.A.3
Daemen, M.J.4
Lutgens, E.5
-
160
-
-
35348910735
-
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis
-
DOI 10.2174/092986707781389664
-
Ferroni, P.; Santilli, F.; Guadagni, F.; Basili, S.; Davi, G. Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis. Curr. Med. Chem., 2007, 14, 2170-2180. (Pubitemid 47591314)
-
(2007)
Current Medicinal Chemistry
, vol.14
, Issue.20
, pp. 2170-2180
-
-
Ferroni, P.1
Santilli, F.2
Guadagni, F.3
Basili, S.4
Davi, G.5
-
161
-
-
0026528181
-
Molecular and biological characterization of a murine ligand for CD40
-
Armitage, R.J.; Fanslow, W.C.; Strockbine, L.; Sato, T.A.; Clifford, K.N.; Macduff, B.M.; Anderson, D.M.; Gimpel, S.D.; Davis-Smith, T.,; Maliszewski, C.R.;.; Clark E.A.; Smith, C.A.; Grabstein, K.H.; Cosman, D.; Spriggs, M.K. Molecular and biological characterization of a murine ligand for CD40. Nature, 1992, 357, 80-82.
-
(1992)
Nature
, vol.357
, pp. 80-82
-
-
Armitage, R.J.1
Fanslow, W.C.2
Strockbine, L.3
Sato, T.A.4
Clifford, K.N.5
Macduff, B.M.6
Anderson, D.M.7
Gimpel, S.D.8
Davis-Smith, T.9
Maliszewski, C.R.10
Clark, E.A.11
Smith, C.A.12
Grabstein, K.H.13
Cosman, D.14
Spriggs, M.K.15
-
162
-
-
0026441086
-
Cloning of TRAP, a ligand for CD40 on human T cells
-
Graf, D.; Korthäuer, U.; Mages, H.W.; Senger, G.; Kroczek, R.A. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol., 1992, 22, 3191-3194.
-
(1992)
Eur. J. Immunol.
, vol.22
, pp. 3191-3194
-
-
Graf, D.1
Korthäuer, U.2
Mages, H.W.3
Senger, G.4
Kroczek, R.A.5
-
163
-
-
0026535399
-
Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help
-
Lederman, S.; Yellin, M.J.; Krichevsky, A.; Belko, J.; Lee, J.J.; Chess, L. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med., 1992, 175, 1091-1101.
-
(1992)
J. Exp. Med.
, vol.175
, pp. 1091-1101
-
-
Lederman, S.1
Yellin, M.J.2
Krichevsky, A.3
Belko, J.4
Lee, J.J.5
Chess, L.6
-
164
-
-
0027427165
-
Induction of human IgE synthesis in B cells by mast cells and basophils
-
DOI 10.1038/365340a0
-
Gauchat, J.F.; Henchoz, S.; Mazzei, G.; Aubry, J.P.; Brunner, T.; Blasey, H.; Life, P.; Talabot, D.; Flores-Romo, L.; Thompson, J.; Kishi, K.; Butterfield, J.; Dahinden, C.; Bonnefoy, J.Y. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature, 1993, 365, 340-343. (Pubitemid 23288974)
-
(1993)
Nature
, vol.365
, Issue.6444
, pp. 340-343
-
-
Gauchat, J.-F.1
Henchoz, S.2
Mazzei, G.3
Aubry, J.-P.4
Brunner, T.5
Blasey, H.6
Life, P.7
Talabot, D.8
Flores-Romo, L.9
Thompson, J.10
Kishi, K.11
Butterfield, J.12
Dahinden, C.13
Bonnefoy, J.-Y.14
-
165
-
-
0027533185
-
Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM
-
DOI 10.1038/361539a0
-
Korthäuer, U.; Graf, D.; Mages, H.W.; Brière, F.; Padayachee, M.; Malcolm, S.; Ugazio, A,G.; Notarangelo, L.D.; Levinsky, R.J.; Kroczek, R.A. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature, 1993, 361, 539-541. (Pubitemid 23055615)
-
(1993)
Nature
, vol.361
, Issue.6412
, pp. 539-541
-
-
Korthauer, U.1
Graf, D.2
Mages, H.W.3
Briere, F.4
Padayachee, M.5
Malcolm, S.6
Ugazio, A.G.7
Notarangelo, L.D.8
Levinsky, R.J.9
Kroczek, R.A.10
-
166
-
-
77954482405
-
CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin αIIbβ3
-
Choi, W.S.; Jeon, O.H.; Kim, D.S. CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin αIIbβ3. J. Thromb. Haemost., 2010, 8, 1364-1371.
-
(2010)
J. Thromb. Haemost.
, vol.8
, pp. 1364-1371
-
-
Choi, W.S.1
Jeon, O.H.2
Kim, D.S.3
-
167
-
-
77950021632
-
Thromboxane A(2) promotes soluble CD40 ligand release from human platelets
-
Enomoto, Y.; Adachi, S.; Matsushima-Nishiwaki, R.; Doi, T.; Niwa, M.; Akamatsu, S.; Tokuda, H.; Ogura, S.; Yoshimura, S.; Iwama, T.; Kozawa, O. Thromboxane A(2) promotes soluble CD40 ligand release from human platelets. Atherosclerosis, 2010, 209, 415-21.
-
(2010)
Atherosclerosis
, vol.209
, pp. 415-21
-
-
Enomoto, Y.1
Adachi, S.2
Matsushima-Nishiwaki, R.3
Doi, T.4
Niwa, M.5
Akamatsu, S.6
Tokuda, H.7
Ogura, S.8
Yoshimura, S.9
Iwama, T.10
Kozawa, O.11
-
168
-
-
0035280017
-
Characterization of soluble CD40 ligand released from human activated platelets
-
Jin, Y.; Nonoyama, S.; Morio, T.; Imai, K.; Ochs, H.D.; Mizutani, S. Characterization of soluble CD40 ligand released from human activated platelets. J. Med. Dent. Sci., 2001, 48, 23-27. (Pubitemid 33735591)
-
(2001)
Journal of Medical and Dental Sciences
, vol.48
, Issue.1
, pp. 23-27
-
-
Jin, Y.1
Nonoyama, S.2
Morio, T.3
Imai, K.4
Ochs, H.D.5
Mizutani, S.6
-
169
-
-
0029915835
-
Human native soluble CD40L is a biologically active trimer, processed inside microsomes
-
DOI 10.1074/jbc.271.11.5965
-
Pietravalle, F.; Lecoanet-Henchoz, S.; Blasey, H.; Aubry, J.P.; Elson, G.; Edgerton, M.D.; Bonnefoy, J.Y.; Gauchat, J.F. Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J. Biol. Chem., 1996, 271, 5965-5967. (Pubitemid 26095393)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.11
, pp. 5965-5967
-
-
Pietravalle, F.1
Lecoanet-Henchoz, S.2
Blasey, H.3
Aubry, J.-P.4
Elson, G.5
Edgerton, M.D.6
Bonnefoy, J.-Y.7
Gauchat, J.-F.8
-
170
-
-
0036130828
-
3 integrin-dependent mechanism
-
DOI 10.1038/nm0302-247
-
André, P.; Prasad, K.C.; Denis, C.V.; He, M.; Papalia, J.M.; Hynes, R.O.; Phillips, D.R.; Wagner, D.D. CD40L stabilizes arterila thrombi by a β3 integrin-dependent mechanism. Nat. Med., 2002, 8, 247-252. (Pubitemid 34250102)
-
(2002)
Nature Medicine
, vol.8
, Issue.3
, pp. 247-252
-
-
Andre, P.1
Srinivasa Prasad, K.S.2
Denis, C.V.3
He, M.4
Papalia, J.M.5
Hynes, R.O.6
Phillips, D.R.7
Wagner, D.D.8
-
171
-
-
0142091359
-
3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling
-
DOI 10.1073/pnas.2032886100
-
Prasad, K.S.; André, P.; He, M.; Bao, M.; Manganello, J.; Phillips, D.R. Soluble CD40L induces 3 integrin tyrosine phosphorylation and triggers platelet activation outside-in signaling. Proc. Natl. Acad. Sci. USA, 2003, 100, 12367-12371. (Pubitemid 37271566)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.21
, pp. 12367-12371
-
-
Prasad, K.S.S.1
Andre, P.2
He, M.3
Bao, M.4
Manganello, J.5
Phillips, D.R.6
-
172
-
-
0038445960
-
Platelet-mediated modulation of adaptive immunity: A communication link between innate and adaptive immune compartments
-
DOI 10.1016/S1074-7613(03)00177-8
-
Elzey, B.D.; Tian, J.; Jensen, R.J.; Swanson, A.K.; Lees, J.R.; Lentz, S.R.; Stein, C.S.; Nieswandt, B.; Wang, Y.; Davidson, B.L.; Ratliff, T.L. Plateletmediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity, 2003, 19, 9-19. (Pubitemid 36859897)
-
(2003)
Immunity
, vol.19
, Issue.1
, pp. 9-19
-
-
Elzey, B.D.1
Tian, J.2
Jensen, R.J.3
Swanson, A.K.4
Lees, J.R.5
Lentz, S.R.6
Stein, C.S.7
Nieswandt, B.8
Wang, Y.9
Davidson, B.L.10
Ratliff, T.L.11
-
173
-
-
43549095273
-
Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge
-
Elzey, B.D.; Schmidt, N.W.; Crist, S.A.; Kresowik, T.P.; Harty, J.T.; Nieswandt, B.; Ratliff, T.L. Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood, 2008, 111, 3684-3691.
-
(2008)
Blood
, vol.111
, pp. 3684-3691
-
-
Elzey, B.D.1
Schmidt, N.W.2
Crist, S.A.3
Kresowik, T.P.4
Harty, J.T.5
Nieswandt, B.6
Ratliff, T.L.7
-
174
-
-
34548137713
-
Human platelets can activate peripheral blood B cells and increase production of immunoglobulins
-
DOI 10.1016/j.exphem.2007.05.021, PII S0301472X07003517
-
Cognasse, F.; Hamzeh-Cognasse, H.; Lafarge, S.; Chavarin, P.; Cogné, M.; Richard, Y.; Garraud, O. Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. Exp. Hematol., 2007, 35, 1376-1387. (Pubitemid 47302591)
-
(2007)
Experimental Hematology
, vol.35
, Issue.9
, pp. 1376-1387
-
-
Cognasse, F.1
Hamzeh-Cognasse, H.2
Lafarge, S.3
Chavarin, P.4
Cogne, M.5
Richard, Y.6
Garraud, O.7
-
175
-
-
79951944691
-
Platelet CD40L at the interface of adaptive immunity
-
Elzey, B.D.; Ratliff, T.L.; Sowa, J.M.; Crist, S.A. Platelet CD40L at the interface of adaptive immunity. Thromb. Res., 2011, 127, 180-183.
-
(2011)
Thromb. Res.
, vol.127
, pp. 180-183
-
-
Elzey, B.D.1
Ratliff, T.L.2
Sowa, J.M.3
Crist, S.A.4
-
176
-
-
42049091649
-
CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury
-
DOI 10.2353/ajpath.2008.070633
-
Li, G.; Sanders, J.M.; Bevard, M.H.; Sun, Z.; Chumley, J.W.; Galkina, E.V.; Ley, K.; Sarembock, I.J. CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am. J. Pathol., 2008, 172, 1141-1152. (Pubitemid 351520009)
-
(2008)
American Journal of Pathology
, vol.172
, Issue.4
, pp. 1141-1152
-
-
Li, G.1
Sanders, J.M.2
Bevard, M.H.3
Sun, Z.4
Chumley, J.W.5
Galkina, E.V.6
Ley, K.7
Sarembock, I.J.8
-
177
-
-
34247527793
-
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1
-
DOI 10.1161/CIRCULATIONAHA.106.683201
-
Zirlik, A.; Maier, C.; Gerdes, N.; MacFarlane, L.; Soosairajah, J.; Bavendiek, U.; Ahrens, I.; Ernst, S.; Bassler, N.; Missiou, A.; Patko, Z.; Aikawa, M.; Schönbeck, U.; Bode, C.; Libby, P.; Peter, K. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation, 2007, 115, 1571-1580. (Pubitemid 46648642)
-
(2007)
Circulation
, vol.115
, Issue.12
, pp. 1571-1580
-
-
Zirlik, A.1
Maier, C.2
Gerdes, N.3
MacFarlane, L.4
Soosairajah, J.5
Bavendiek, U.6
Ahrens, I.7
Ernst, S.8
Bassler, N.9
Missiou, A.10
Patko, Z.11
Aikawa, M.12
Schonbeck, U.13
Bode, C.14
Libby, P.15
Peter, K.16
-
178
-
-
78549272749
-
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis
-
Lievens, D.; Zernecke, A.; Seijkens, T.; Soehnlein, O.; Beckers, L.; Munnix, I.C.; Wijnands, E.; Goossens, P.; van Kruchten, R.; Thevissen, L.; Boon, L.; Flavell, R.A.; Noelle, R.J.; Gerdes, N.; Biessen, E.A.; Daemen, M.J.; Heemskerk, J.W.; Weber, C.; Lutgens, E. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood, 2010, 116, 4317-4327.
-
(2010)
Blood
, vol.116
, pp. 4317-4327
-
-
Lievens, D.1
Zernecke, A.2
Seijkens, T.3
Soehnlein, O.4
Beckers, L.5
Munnix, I.C.6
Wijnands, E.7
Goossens, P.8
Van Kruchten, R.9
Thevissen, L.10
Boon, L.11
Flavell, R.A.12
Noelle, R.J.13
Gerdes, N.14
Biessen, E.A.15
Daemen, M.J.16
Heemskerk, J.W.17
Weber, C.18
Lutgens, E.19
-
179
-
-
0037877918
-
CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation
-
DOI 10.1161/01.RES.0000070111.98158.6C
-
Inwald, D.P.; McDowall, A.; Peters, M.J.; Callard, R.E.; Klein, N.J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ. Res., 2003, 92, 1041-1048. (Pubitemid 36588504)
-
(2003)
Circulation Research
, vol.92
, Issue.9
, pp. 1041-1048
-
-
Inwald, D.P.1
McDowall, A.2
Peters, M.J.3
Callard, R.E.4
Klein, N.J.5
-
180
-
-
79961016308
-
Platelets inflammation and tissue regeneration
-
Nurden, A.T. Platelets, inflammation and tissue regeneration. Thromb. Haemost. Suppl., 2011, S13-33.
-
(2011)
Thromb. Haemost. Suppl.
-
-
Nurden, A.T.1
-
181
-
-
11144238727
-
CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia
-
DOI 10.1016/j.jacc.2004.09.047, PII S0735109704019308
-
Sanguigni, V.; Ferro, D.; Pignatelli, P.; Del Ben, M.; Nadia, T.; Saliola, M.; Sorge, R.; Violi, F. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J. Am. Coll. Cardiol., 2005, 45, 35-42. (Pubitemid 40052023)
-
(2005)
Journal of the American College of Cardiology
, vol.45
, Issue.1
, pp. 35-42
-
-
Sanguigni, V.1
Ferro, D.2
Pignatelli, P.3
Del Ben, M.4
Nadia, T.5
Saliola, M.6
Sorge, R.7
Violi, F.8
-
182
-
-
2942545798
-
Bidirectional relation between inflammation and coagulation
-
DOI 10.1161/01.CIR.0000131660.51520.9A
-
Levi, M.; van der Poll, T.; Büller, H.R. Bidirectional relation between inflammation and coagulation. Circulation, 2004, 109, 2698-2704. (Pubitemid 38737913)
-
(2004)
Circulation
, vol.109
, Issue.22
, pp. 2698-2704
-
-
Levi, M.1
Van Der Poll, T.2
Buller, H.R.3
-
183
-
-
0031907778
-
CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression
-
Miller, D.L.; Yaron, R.; Yellin, M.J. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J. Leukoc. Biol., 1998, 63, 373-379. (Pubitemid 28106852)
-
(1998)
Journal of Leukocyte Biology
, vol.63
, Issue.3
, pp. 373-379
-
-
Miller, D.L.1
Yaron, R.2
Yellin, M.J.3
-
184
-
-
33646386437
-
Internalization of CD40 regulates its signal transduction in vascular endothelial cells
-
Chen, Y.; Chen, J.; Xiong, Y.; Da, Q.; Xu, Y.; Jiang, X.; Tang, H. Internalization of CD40 regulates its signal transduction in vascular endothelial cells. Biochem. Biophys. Res. Commun., 2006, 345, 106-117.
-
(2006)
Biochem. Biophys. Res. Commun.
, vol.345
, pp. 106-117
-
-
Chen, Y.1
Chen, J.2
Xiong, Y.3
Da, Q.4
Xu, Y.5
Jiang, X.6
Tang, H.7
-
185
-
-
54049156519
-
Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells
-
Chen, C.; Chai, H.; Wang, X.; Jiang, J.; Jamaluddin, M.S.; Liao, D.; Zhang, Y.; Wang, H.; Bharadwaj, U.; Zhang, S.; Li, M.; Lin, P.; Yao, Q. Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood, 2008, 112, 3205-3216.
-
(2008)
Blood
, vol.112
, pp. 3205-3216
-
-
Chen, C.1
Chai, H.2
Wang, X.3
Jiang, J.4
Jamaluddin, M.S.5
Liao, D.6
Zhang, Y.7
Wang, H.8
Bharadwaj, U.9
Zhang, S.10
Li, M.11
Lin, P.12
Yao, Q.13
-
186
-
-
0037456769
-
Soluble CD40 ligand in acute coronary syndromes
-
DOI 10.1056/NEJMoa022600
-
Heeschen, C.; Dimmeler, S.; Hamm, C.W.; van den Brand, M.J.; Boersma, E.; Zeiher, A.M.; Simoons, M.L.; CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes. N. Engl. J. Med., 2003, 348, 1104-1111. (Pubitemid 36337321)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.12
, pp. 1104-1111
-
-
Heeschen, C.1
Dimmeler, S.2
Hamm, C.W.3
Van Den Brand, M.J.4
Boersma, E.5
Zeiher, A.M.6
Simoons, M.L.7
-
187
-
-
0344850187
-
Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
-
Aukurst, P.; Muller, F.; Ueland, T.; Berget, T.; Aaser, E.; Brunsvig, A.; Solum, N.O.; Forfang, K.; Frøland, S.S.; Gullestad, L. Enhanced levels of soluble CD40L in patients with unstable angina. Possible reflection of Tlymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation, 1999, 100, 614-620. (Pubitemid 29379750)
-
(1999)
Circulation
, vol.100
, Issue.6
, pp. 614-620
-
-
Aukrust, P.1
Muller, F.2
Ueland, T.3
Berget, T.4
Aaser, E.5
Brunsvig, A.6
Solum, N.O.7
Forfang, K.8
Froland, S.S.9
Gullestad, L.10
-
188
-
-
0038652166
-
Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia
-
Garlichs, C.D.; Kozina, S.; Fateh-Moghadam, S.; Handschu, R.; Tomandl, B.; Stumpf, C.; Eskafi, S.; Raaz, D.; Schmeisser, A.; Yilmaz, A.; Ludwig, J.; Neundörfer, B.; Daniel, W.G. Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke, 2003, 34, 1412-1418.
-
(2003)
Stroke
, vol.34
, pp. 1412-1418
-
-
Garlichs, C.D.1
Kozina, S.2
Fateh-Moghadam, S.3
Handschu, R.4
Tomandl, B.5
Stumpf, C.6
Eskafi, S.7
Raaz, D.8
Schmeisser, A.9
Yilmaz, A.10
Ludwig, J.11
Neundörfer, B.12
Daniel, W.G.13
-
189
-
-
33745150387
-
Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease
-
Balla, J.; Magyar, M.T.; Bereczki, D.; Valikovics, A.; Nagy, E.; Barna, E.; Pál, A.; Balla, G.; Csiba, L.; Blaskó, G. Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease. Dis. Markers, 2006, 22, 133-140. (Pubitemid 43893792)
-
(2006)
Disease Markers
, vol.22
, Issue.3
, pp. 133-140
-
-
Balla, J.1
Magyar, M.T.2
Bereczki, D.3
Valikovics, A.4
Nagy, E.5
Barna, E.6
Pal, A.7
Balla, G.8
Csiba, L.9
Blasko, G.10
-
190
-
-
0037461106
-
Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease
-
DOI 10.1161/01.CIR.0000069272.06194.91
-
Marx, N.; Imhof, A.; Frohelich, J.; Siam, L.; Ittner, J.; Wierse, G.; Schmidt, A.; Maerz, W.; Hombach, V.; Koenig, W. Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease. Circulation, 2003, 107, 1954-1957. (Pubitemid 36506065)
-
(2003)
Circulation
, vol.107
, Issue.15
, pp. 1954-1957
-
-
Marx, N.1
Imhof, A.2
Froehlich, J.3
Siam, L.4
Ittner, J.5
Wierse, G.6
Schmidt, A.7
Maerz, W.8
Hombach, V.9
Koenig, W.10
-
191
-
-
77955020141
-
Levels of sCD40 ligand in chronic and acute coronary syndromes and its relation to angiographic extent of coronary arterial narrowing
-
Fouad, H.H.; Al-Dera, H.; Bakhoum, S.W.; Rashed, L.A.; Sayed, R.H.; Rateb, M.A.; Haidara, M.A.; Soskic, S.; Isenovic, E.R. Levels of sCD40 ligand in chronic and acute coronary syndromes and its relation to angiographic extent of coronary arterial narrowing. Angiology, 2010, 61, 567-573.
-
(2010)
Angiology
, vol.61
, pp. 567-573
-
-
Fouad, H.H.1
Al-Dera, H.2
Bakhoum, S.W.3
Rashed, L.A.4
Sayed, R.H.5
Rateb, M.A.6
Haidara, M.A.7
Soskic, S.8
Isenovic, E.R.9
-
192
-
-
0035818509
-
Soluble CD40L and cardiovascular risk in women
-
Schönbeck, U.; Varo, N.; Libby, P.; Buring, J.; Ridker, P.M. Soluble CD40L and cardiovascular risk in women. Circulation, 2001,104, 2266-2268. (Pubitemid 33049505)
-
(2001)
Circulation
, vol.104
, Issue.19
, pp. 2266-2268
-
-
Schonbeck, U.1
Varo, N.2
Libby, P.3
Buring, J.4
Ridker, P.M.5
-
193
-
-
36348929899
-
Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation
-
DOI 10.1161/ATVBAHA.107.152777, PII 0004360520071200000040
-
Ferro, D.; Loffredo, L.; Polimeni, L.; Fimognari, F.; Villari, P.; Pignatelli, P.; Fuster, V.; Violi, F. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Arterioscler. Thromb. Vasc. Biol., 2007, 27, 2763-2768. (Pubitemid 350158934)
-
(2007)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.27
, Issue.12
, pp. 2763-2768
-
-
Ferro, D.1
Loffredo, L.2
Polimeni, L.3
Fimognari, F.4
Villari, P.5
Pignatelli, P.6
Fuster, V.7
Violi, F.8
-
194
-
-
56049105881
-
Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16
-
Olenchock, B.A.; Wiviott, S.D.; Murphy, S.A.; Cannon, C.P.; Rifai, N.; Braunwald, E.; Morrow, D.A. Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16. J. Thromb. Thrombolysis, 2008, 26, 79-84.
-
(2008)
J. Thromb. Thrombolysis
, vol.26
, pp. 79-84
-
-
Olenchock, B.A.1
Wiviott, S.D.2
Murphy, S.A.3
Cannon, C.P.4
Rifai, N.5
Braunwald, E.6
Morrow, D.A.7
-
195
-
-
34248339495
-
Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome
-
DOI 10.1373/clinchem.2006.080192
-
Apple FS, Pearce LA, Chung A, Ler R, Murakami MM. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin. Chem., 2007, 53, 874-881. (Pubitemid 46744243)
-
(2007)
Clinical Chemistry
, vol.53
, Issue.5
, pp. 874-881
-
-
Apple, F.S.1
Pearce, L.A.2
Chung, A.3
Ler, R.4
Murakami, M.M.5
-
196
-
-
0035163042
-
Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus
-
Davis, J.C. Jr., Totoritis, M.C.; Rosenberg, J.; Sklenar, T.A.; Wofsy, D. Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus. J. Rheumatol., 2001, 28, 95-101. (Pubitemid 32062030)
-
(2001)
Journal of Rheumatology
, vol.28
, Issue.1
, pp. 95-101
-
-
Davis Jr. J.C.Totoritis, M.C.1
Rosenberg, J.2
Sklenar, T.A.3
Wofsy, D.4
-
197
-
-
78650420516
-
Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2/Rac1/p38 mitogen-activated protein kinase signaling pathway
-
Yacoub, D.; Hachem, A.; Théorét, J.F.; Gillis, M.A.; Mourad, W.; Merhi, Y. Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2/Rac1/p38 mitogen-activated protein kinase signaling pathway. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 2424-2433.
-
(2010)
Arterioscler. Thromb. Vasc. Biol.
, vol.30
, pp. 2424-2433
-
-
Yacoub, D.1
Hachem, A.2
Théorét, J.F.3
Gillis, M.A.4
Mourad, W.5
Merhi, Y.6
-
198
-
-
79952058549
-
Microvascular thrombosis and CD40/CD40L signaling
-
Gavins, F.N.; Li, G.; Russell, J.; Perretti, M.; Granger, D.N. Microvascular thrombosis and CD40/CD40L signaling. J. Thromb. Haemost., 2011, 9, 574-581.
-
(2011)
J. Thromb. Haemost.
, vol.9
, pp. 574-581
-
-
Gavins, F.N.1
Li, G.2
Russell, J.3
Perretti, M.4
Granger, D.N.5
-
199
-
-
2642608661
-
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
-
DOI 10.1038/28204
-
Mach, F.; Schönbeck, U.; Sukhova, G.K.; Atkinson, E.; Libby, P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature, 1998, 394, 200-203. (Pubitemid 28325976)
-
(1998)
Nature
, vol.394
, Issue.6689
, pp. 200-203
-
-
Mach, F.1
Schonbeck, U.2
Sukhova, G.K.3
Atkinson, E.4
Libby, P.5
-
200
-
-
0032740818
-
Requirement for CD154 in the progression of atherosclerosis
-
DOI 10.1038/15271
-
Lutgens, E.; Gorelik, L.; Daemen, M.J.; de Muinck, E.D.; Grewal, I.S.; Koteliansky, V.E.; Flavell, R.A. Requirement for CD154 in the progression of atherosclerosis. Nat. Med., 1999, 5, 1313-6. (Pubitemid 29535611)
-
(1999)
Nature Medicine
, vol.5
, Issue.11
, pp. 1313-1316
-
-
Lutgens, E.1
Gorelik, L.2
Daemen, M.J.A.P.3
De Muinck, E.D.4
Grewal, I.S.5
Koteliansky, V.E.6
Flavell, R.A.7
-
201
-
-
0034691040
-
Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
-
DOI 10.1073/pnas.97.13.7464
-
Lutgens, E.; Cleutjens, K.B.; Heeneman, S.; Koteliansky, V.E.; Burkly, L.C.; Daemen, M.J. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc. Natl. Acad. Sci. U S A., 2000, 97, 7464-7469. (Pubitemid 30431486)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.13
, pp. 7464-7469
-
-
Lutgens, E.1
Cleutjens, K.B.J.M.2
Heeneman, S.3
Koteliansky, V.E.4
Burkly, L.C.5
Daemen, M.J.A.P.6
-
202
-
-
77149136451
-
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile
-
Lutgens, E.; Lievens, D.; Beckers, L.; Wijnands, E.; Soehnlein, O.; Zernecke, A.; Seijkens, T.; Engel, D.; Cleutjens, J.; Keller, A.M.; Naik, S.H.; Boon, L.; Oufella, H.A.; Mallat, Z.,; Ahonen, C.L.; Noelle, R.J.; de Winther, M.P.; Daemen, M.J.; Biessen, E.A.; Weber, C. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J. Exp. Med., 2010, 207, 391-404.
-
(2010)
J. Exp. Med.
, vol.207
, pp. 391-404
-
-
Lutgens, E.1
Lievens, D.2
Beckers, L.3
Wijnands, E.4
Soehnlein, O.5
Zernecke, A.6
Seijkens, T.7
Engel, D.8
Cleutjens, J.9
Keller, A.M.10
Naik, S.H.11
Boon, L.12
Oufella, H.A.13
Mallat, Z.14
Ahonen, C.L.15
Noelle, R.J.16
De Winther, M.P.17
Daemen, M.J.18
Biessen, E.A.19
Weber, C.20
more..
-
203
-
-
33746154921
-
Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels
-
DOI 10.1016/j.clinthera.2006.06.010, PII S0149291806001469
-
Vavuranakis, M.; Latsios, G.; Aggelis, D.; Bosinakou, I.; Karambelas, I.; Tousoulis, D.; Toutouzas, K.; Stefanadis, C. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity Creactive protein and soluble CD40 ligand levels. Clin. Ther., 2006, 28, 860-871. (Pubitemid 44081951)
-
(2006)
Clinical Therapeutics
, vol.28
, Issue.6
, pp. 860-871
-
-
Vavuranakis, M.1
Latsios, G.2
Aggelis, D.3
Bosinakou, I.4
Karambelas, I.5
Tousoulis, D.6
Toutouzas, K.7
Stefanadis, C.8
-
204
-
-
33745960097
-
Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: Evidence for antioxidant and antiinflammatory effects
-
DOI 10.1161/01.ATV.0000225288.74170.dc, PII 0004360520060700000038
-
Heitzer, T.; Rudolph, V.; Schwedhelm, E.; Karstens, M.; Sydow, K.; Ortak, M.; Tschentscher, P.; Meinertz, T.; Böger, R.; Baldus, S. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: Evidence for antioxidant and antiinflammatory effects. Arterioscler. Thromb. Vasc. Biol., 2006, 26, 1648-1652. (Pubitemid 44288996)
-
(2006)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.26
, Issue.7
, pp. 1648-1652
-
-
Heitzer, T.1
Rudolph, V.2
Schwedhelm, E.3
Karstens, M.4
Sydow, K.5
Ortak, M.6
Tschentscher, P.7
Meinertz, T.8
Boger, R.9
Baldus, S.10
-
205
-
-
33748081769
-
Clopidogrel reduces platelet-leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus [10]
-
DOI 10.1136/hrt.2005.083006
-
Harding, S.A.; Sarma, J.; Din, J.N.; Maciocia, P.M.; Newby, D.E.; Fox, K.A. Clopidogrel reduces platelet-leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus. Heart, 2006, 92, 1335-1337. (Pubitemid 44298905)
-
(2006)
Heart
, vol.92
, Issue.9
, pp. 1335-1337
-
-
Harding, S.A.1
Sarma, J.2
Din, J.N.3
Maciocia, P.M.4
Newby, D.E.5
Fox, K.A.A.6
-
206
-
-
1542722301
-
Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention
-
DOI 10.1016/j.amjcard.2003.11.048, PII S0002914903016953
-
Quinn, M.J.; Bhatt, D.L.; Zidar, F.; Vivekananthan, D.; Chew, D.P.; Ellis, S.G.; Plow, E.; Topol, E.J. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am. J. Cardiol., 2004, 93, 679-684. (Pubitemid 38338553)
-
(2004)
American Journal of Cardiology
, vol.93
, Issue.6
, pp. 679-684
-
-
Quinn, M.J.1
Bhatt, D.L.2
Zidar, F.3
Vivekananthan, D.4
Chew, D.P.5
Ellis, S.G.6
Plow, E.7
Topol, E.J.8
-
207
-
-
2542488125
-
Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome
-
DOI 10.1016/j.jacc.2003.10.071, PII S0735109704004978
-
Xiao, Z.; Théroux, P. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. J Am. Coll. Cardiol., 2004, 43, 1982-1988. (Pubitemid 38686790)
-
(2004)
Journal of the American College of Cardiology
, vol.43
, Issue.11
, pp. 1982-1988
-
-
Xiao, Z.1
Theroux, P.2
-
208
-
-
0037374428
-
Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease
-
DOI 10.1067/mcp.2003.13
-
Klinkhardt, U.; Bauersachs, R.; Adams, J.; Graff, J.; Lindhoff-Last, E.; Harder, S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin. Pharmacol. Ther., 2003, 73, 232-41. (Pubitemid 36269674)
-
(2003)
Clinical Pharmacology and Therapeutics
, vol.73
, Issue.3
, pp. 232-241
-
-
Klinkhardt, U.1
Bauersachs, R.2
Adams, J.3
Graff, J.4
Lindhoff-Last, E.5
Harder, S.6
-
209
-
-
28144434957
-
Anti-inflammatory effects of clopidogrel intake in renal transplant patients: Effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers
-
DOI 10.1016/j.clpt.2005.08.002, PII S000992360500319X
-
Graff, J.; Harder, S.; Wahl, O.; Scheuermann, E.H.; Gossmann, J. Antiinflammatory effects of clopidogrel intake in renal transplant patients: Effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers. Clin. Pharmacol. Ther., 2005, 78, 468-476. (Pubitemid 41698901)
-
(2005)
Clinical Pharmacology and Therapeutics
, vol.78
, Issue.5
, pp. 468-476
-
-
Graff, J.1
Harder, S.2
Wahl, O.3
Scheuermann, E.-H.4
Gossmann, J.5
-
210
-
-
33751224446
-
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease
-
DOI 10.1160/TH06-06-0337
-
Solheim, S,; Pettersen, A.A.; Arnesen, H.; Seljeflot, I. No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease. Thromb. Haemost., 2006, 96, 660-664. (Pubitemid 44782547)
-
(2006)
Thrombosis and Haemostasis
, vol.96
, Issue.5
, pp. 660-664
-
-
Solheim, S.1
Pettersen, A.A.2
Arnesen, H.3
Seljeflot, I.4
-
211
-
-
76549106922
-
Regulation of CD40L (CD154) and CD62P (pselectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients
-
Chandler, A.B.; Earhart, A.D.; Speich, H.E.; Kueter, T.J.; Hansen, J.; White, M.M.; Jennings, L.K. Regulation of CD40L (CD154) and CD62P (pselectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients. Thromb. Res., 2010, 125, 44-52.
-
(2010)
Thromb. Res.
, vol.125
, pp. 44-52
-
-
Chandler, A.B.1
Earhart, A.D.2
Speich, H.E.3
Kueter, T.J.4
Hansen, J.5
White, M.M.6
Jennings, L.K.7
-
212
-
-
0742305175
-
GP IIb/IIIa Inhibition with Eptifibatide Lowers Levels of Soluble CD40L and RANTES after Percutaneous Coronary Intervention
-
DOI 10.1002/ccd.10763
-
Welt, F.G.; Rogers, S.D.; Zhang, X.; Ehlers, R.; Chen, Z.; Nannizzi-Alaimo, L.; Phillips, D.R.; Simon, D.I. GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention. Catheter. Cardiovasc. Interv., 2004, 61, 185-189. (Pubitemid 38160615)
-
(2004)
Catheterization and Cardiovascular Interventions
, vol.61
, Issue.2
, pp. 185-189
-
-
Welt, F.G.P.1
Rogers, S.D.2
Zhang, X.3
Ehlers, R.4
Chen, Z.5
Nannizzi-Alaimo, L.6
Phillips, D.R.7
Simon, D.I.8
-
213
-
-
80052625934
-
Platelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascularization
-
Haller, S.; Adlakha, S.; Reed, G.; Brewster, P.; Kennedy, D.; Burket, M.W.; Colyer, W.; Yu, H.; Zhang, D.; Shapiro, J.I.; Cooper, C.J. Platelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascularization. Clin. J. Am. Soc. Nephrol., 2011, 6, 2185-2891.
-
(2011)
Clin. J. Am. Soc. Nephrol.
, vol.6
, pp. 2185-2891
-
-
Haller, S.1
Adlakha, S.2
Reed, G.3
Brewster, P.4
Kennedy, D.5
Burket, M.W.6
Colyer, W.7
Yu, H.8
Zhang, D.9
Shapiro, J.I.10
Cooper, C.J.11
-
214
-
-
0042915934
-
Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: A subgroup analysis from the GUSTO V and FASTER trials
-
DOI 10.1023/A:1025044625487
-
Bertram, U.; Moser, M.; Peter, K.; Kuecherer, H.F.; Bekeredjian, R.; Straub, A.; Nordt, T.K.; Bode, C.; Ruef, J. Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: A subgroup analysis from the GUSTO V and FASTER trials. J. Thromb. Thrombolysis., 2002, 14, 197-203. (Pubitemid 37069302)
-
(2002)
Journal of Thrombosis and Thrombolysis
, vol.14
, Issue.3
, pp. 197-203
-
-
Bertram, U.1
Moser, M.2
Peter, K.3
Kuecherer, H.F.4
Bekeredjian, R.5
Straub, A.6
Nordt, T.K.7
Bode, C.8
Ruef, J.9
-
215
-
-
75149130574
-
High-dose tirofiban with enoxaparin and inflammatory markers in high-risk percutaneous intervention
-
Walters, D.L.; Ray, M.J.; Wood, P.; Perrin, E.J.; Bett, J.H.; Aroney, C.N. High-dose tirofiban with enoxaparin and inflammatory markers in high-risk percutaneous intervention. Eur. J. Clin. Invest., 2010, 40, 139-147.
-
(2010)
Eur. J. Clin. Invest.
, vol.40
, pp. 139-147
-
-
Walters, D.L.1
Ray, M.J.2
Wood, P.3
Perrin, E.J.4
Bett, J.H.5
Aroney, C.N.6
-
216
-
-
79961053104
-
Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on plateletderived microparticles in patients with peripheral arterial occlusive disease
-
Mobarrez, F.; He, S.; Bröijersen, A.; Wiklund, B.; Antovic, A.; Antovic, J.; Egberg, N.; Jörneskog, G.; Wallén, H. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on plateletderived microparticles in patients with peripheral arterial occlusive disease. Thromb. Haemost., 2011, 106, 344-352.
-
(2011)
Thromb. Haemost.
, vol.106
, pp. 344-352
-
-
Mobarrez, F.1
He, S.2
Bröijersen, A.3
Wiklund, B.4
Antovic, A.5
Antovic, J.6
Egberg, N.7
Jörneskog, G.8
Wallén, H.9
-
217
-
-
79959441185
-
Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia
-
Serebruany, V.L.; Miller, M.; Pokov, A.N.; Lynch, D.; Jensen, J.K.; Hallén, J.; Atar, D. Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia. Cardiology, 2011, 118, 187-194.
-
(2011)
Cardiology
, vol.118
, pp. 187-194
-
-
Serebruany, V.L.1
Miller, M.2
Pokov, A.N.3
Lynch, D.4
Jensen, J.K.5
Hallén, J.6
Atar, D.7
-
218
-
-
42249105887
-
Platelet GPIb complex as a target for anti-thrombotic drug development
-
DOI 10.1160/TH07-12-0718
-
Clemetson, K.J.; Clemetson, J.M. Platelet GPIb complex as a target for antithrombotic drug development. Thromb. Haemost., 2008, 99, 473-479. (Pubitemid 351549283)
-
(2008)
Thrombosis and Haemostasis
, vol.99
, Issue.3
, pp. 473-479
-
-
Clemetson, K.J.1
Clemetson, J.M.2
-
219
-
-
34548800393
-
Collagen receptors as potential targets for novel anti-platelet agents
-
DOI 10.2174/138161207781662894
-
Clemetson, K.J.; Clemetson, J.M. Collagen receptors as potential targets for novel anti-platelet agents. Curr. Pharm. Des., 2007, 13, 2673-2683. (Pubitemid 47423660)
-
(2007)
Current Pharmaceutical Design
, vol.13
, Issue.26
, pp. 2673-2683
-
-
Clemetson, K.J.1
Clemetson, J.M.2
|